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ABSTRACT 
 
Helminth infections are highly prevalent in sub-Saharan Africa (SSA) where over 40% of 
women of child bearing age are infected with helminths.  Strong associations have been 
made with maternal helminth infection and impaired immune response to standard 
childhood vaccinations. For example, generation of protective antibody to Heamophilus 
influenzae type b post vaccination is inversely proportional to the number of maternal 
helminth infections during pregnancy. The neonatal immune system is immature and 
represents a period of general increased susceptibility to infectious disease. It is known that 
the neonatal immune system is naturally biased towards a Th2 response and the capacity to 
generate a Th1 response is compromised. Mouse studies have shown that passive maternal 
antibodies (MatAb) influence development of the B cell repertoire of offspring. Neonates 
are highly dependent upon MatAb for protection against a wide range of pathogens; 
however MatAb can suppress an infant’s primary antibody response to infection and 
vaccination. Areas with high helminth prevalence also have high prevalence of non-
typhoidal Salmonella infections which lead to progressive bacteraemia in children aged 6-24 
months. Infectious history with Nb impairs the same host’s ability to control subsequent and 
simultaneous STm infection, and impairs efficacy of the Porins vaccine against STm. This 
study investigates imprinting of the murine fetal immune system by maternal infection with 
the helminth Nippostrongylus brasiliensis (Nb) prior to pregnancy and its effect on control of 
the Salmonella enterica serovar typhimurium (STm) in offspring. We show that maternal Nb 
infection in BALB/c mice results in the transfer of Nb antigen (NES)-specific IgG1 in utero and 
through breastmilk, changes in lymphocyte populations and early germinal center formation 
in naive offspring. Maternal Nb infection does not interfere with control of STm in offspring 
in BALB/c mice, but may interfere with control of STm in C57BL/6 mice.  In BALB/c mice, 
serum opsonization experiments with serum from adult offspring born to Nb infected 
mothers showed impaired natural ability to opsonize STm, suggesting that maternal Nb 
infection has long-term functional effects in offspring. These results further our 
understanding of how neonatal immune systems are imprinted by maternal infectious 
history and how this can affect the infant responses against other pathogens in early and 
later life, and give reason for increased deworming, and better neonatal vaccine strategies. 
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1. Introduction 
 
1.1 The Immune System 
The primary function of the immune system is to protect the host from invading pathogens 
by distinguishing self from non-self, mounting an inflammatory response to eliminate the 
foreign infectious agent while maintaining tolerance to ‘self’. These infectious agents range 
from the sub-microscopic virus and the unicellular bacteria to multicellular macroparasites. 
They can be intracellular: all viruses, some bacteria (e.g. Mycobacterium leprae) and some 
parasites (e.g. Plasmodium falciparium), or extracellular: some bacteria (e.g. Streptococcus 
pneumoniae), all fungi and some parasites (e.g. parasitic worms like Ascaris and 
Schistosoma).1 While our growing understanding of the immune system has revealed its 
influence on a variety of different biomedical fields and shed light on many non-
communicable human diseases (e.g. diabetes, multiple sclerosis), resistance to infection is 
still its primary role.2  
 
The immune system is composed of physical and biochemical barriers such as skin, mucus, 
stomach acid and tears, and is maintained by various kinds of leukocytes (immune cells, also 
known as white blood cells) and soluble protein mediators including cytokines and 
antibodies.1 Leukocytes originate from the primary lymphoid organs, the bone marrow and 
thymus, migrate through the blood to secondary lymphoid organs where they detect 
infection in the form of foreign antigen. The three major secondary lymphoid organs are the 
spleen which collects antigen from the blood, the lymph nodes which collect antigen from 
the tissues, and the mucosal-associated lymphoid tissues (MALT) which collect antigen from 
the epithelial surfaces of the body.3 
 
1.2 Innate vs. Adaptive 
The immune system protects the host by fulfilling four main tasks: immunological 
recognition, immune effector functions, immune regulation and immunological memory. 
These tasks are carried out by the co-ordinated efforts of the functionally distinct innate and 
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adaptive responses. The innate response is the non-specific first line of defence and is 
responsible for detecting the pathogen, immediate and rapid control of the infection and, if 
unable to effectively eliminate the pathogen, induction of the adaptive response. The 
adaptive response is slower to provide protection to a primary infection and is characterized 
by its adaptive specificity to that particular pathogen, and generation of immunological 
memory which ensures stronger, more rapid and more specific induction upon re-encounter 
of that pathogen and is the fundamental principle behind vaccination. 
 
1.3 Evolution of the Immune System 
The innate immune response is much more ancient than the adaptive response. Heritable 
innate mechanisms of self-defence are present even in unicellular organisms, which 
appeared 3.5 billion years ago, and every multicellular organism, animal or plant, possesses 
a complex innate immune system.4 Through the phylogen tic study of the key elements of 
an adaptive response, i.e. TCR, BCR, RAG1/RAG2, and MHC class I and class II genes, which 
make possible the recognition and specific attack of a near infinite number of different 
pathogens, evolutionary immunologists have shown that all jawed vertebrates possess an 
adaptive immune response.5,6 The acquisition of this adaptive response is thought to have 
occurred between the divergence of jawed vertebrates (gnathostome) and jawless 
vertebrates (agnathans, of which only hagfish and lampreys still exist), over 500 million 
years ago.7 Therefore, the co-evolution of the innate and adaptive immune systems over the 
last 500 million years has ensured their complementary and inextricably coordinated roles 
in mediating host protection. This interplay requires communication between the cells that 
make up the innate and adaptive response, by cell-to-cell contact and by the secretion and 
binding of cytokines to cell surface receptors. 
  
1.4 Innate Immunity 
The innate response recognizes invading pathogens, attempts to eliminate the pathogen 
and recruits the adaptive response if the infection becomes unmanageable. With the 
exception of natural killer (NK) cells,8 innate leukocytes and soluble proteins are not 
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pathogen specific in their response, have no memory and respond with the same in 
magnitude upon re-encounter with the same pathogen. Recognition occurs through the 
binding of Pathogen Associated Molecular Patterns (PAMPs) to germ line encoded, non-
clonal Pattern Recognition Receptors (PRRs) and Toll Like Receptors (TLRs) on innate cells.9 
PAMPS include highly evolutionarily conserved molecules like LPS, bacterial CpG DNA and 
viral double-stranded RNA which are maintained after pathogen replication within the host.  
 
1.4.1 Innate cells 
Innate cells are hematopoietic cells originating in the bone marrow and include dendritic 
cells (DCs), macrophages, neutrophils, NK cells, mast cells, basophils and eosinophils.10 From 
the bone marrow, immature cells move into the blood where some mature (e.g. NK cells, 
neutrophils) while others leak into tissues by extravasation and mature there (macrophages, 
DCs and mast cells). If there is an infection, cells encounter the foreign antigen and rapidly 
differentiate into short-lived effector cells, each with a different role in eliminating the 
pathogen.1 
 
Professional phagocytic cells which include neutrophils, macrophages, tissue DCs and B cells 
bind to extracellular microbes or cell debris before engulfing and destroying them through 
fusion of the phagosome with acidic lysosomes into a phagolysosome.4 Granulocytes like 
eosinophils and basophils release enzymes which can neutralize pathogens that are too big 
to be phagocytosed, including parasites like helminths.1,11 NK cells can recognise and kill 
tumour cells or cells that are infected with internal pathogens by releasing cytotoxic 
granzymes which cause apoptosis of the target cell.1  A set of innate serum proteins known 
as ‘acute phase proteins’, including C-reactive protein and complement proteins, are 
activated by antibody:antigen complexes or by pathogen surfaces and either directly kill 
pathogens by formation of a membrane attack complex (MAC) by or targeting them for 
phagocytosis.12  
 
Mast cells are non-professional or occasional phagocytes and are important mediators in 
allergic inflammation and asthma. Here they provoke inflammation in response to 
innocuous antigens not associated with pathogens. Mast cells contain preformed granules 
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of chemical mediators like histamine, which are released by mast cell degranulation upon 
cross linking of their high affinity receptors FcεRI with the antibody IgE.1 
 
Phagocytes have multi-layered functions. Macrophages are present in virtually all tissues. 
They are a morphologically diverse and functionally plastic population of cells, taking on 
different morphologies and functions in addition to phagocytosis of pathogens and 
pathogen products. These functions and nomenclature depend on the tissue of residence 
(e.g. skin, liver, spleen, bone, brain, placenta) (Fig 1.1), the type of invading pathogen 
(intracellular vs. extracellular) and duration of the infection (e.g. chronic vs. short-term 
helminth infection).13 Their primary function is, in fact, to act as scavengers and ‘janitor 
cells’ and clear the interstitial environment of cellular debris and apoptotic cells. This occurs 
constantly through recognition via homeostatic receptors and without signalling from other 
immune cells or the production of cytokines.14  
 
Macrophages also act as supervisors of the innate response and recruit other phagocytes to 
the site of infection through secretion of chemotactic cytokines called chemokines.4 
Importantly, macrophages function as immune surveillance cells which respond differently 
depending on the type of pathogen they encounter. Classically activated macrophages 
(CAMs) or M1 macrophages respond to intracellular pathogens like a variety of bacteria, 
viruses and protozoa, as well as during tumorigenesis, where they induce an inflammatory 
killing immune response. Alternatively activated macrophages (AAMs) or M2 macrophages 
respond to some extracellular pathogens and have regulatory functions. They are activated 
in chronic infection with helminths15 wound healing where they have a suppressive 
immunomodulatory roles. They are also involved in allergic responses but their role here is 
controversial, some studies suggesting that they promote allergic inflammation and others 
suggesting a suppressive role.16 Specialized tumour associated macrophages (TAMs) have 
antitumour immunity. Myeloid-derived suppressor cells (MDSCs) are a group of immature 
cells which include the precursors to AAMs and TAMs, exhibiting immune suppressive 
activity.13 
 
A recently discovered population of innate cells called nuocytes has been shown to activate 
responses against helminths by secreting cytokines which polarize adaptive immunity 
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towards helminth specific T cell responses.17 DCs primarily act as highly specialized antigen-
presenting cells (APCs) which internalize pathogens and foreign proteins and move to lymph 
nodes where they present the processed antigen and thereby signal to T cells that 
reinforcements are needed. DC antigen presentation to and activation of T cells, 
macrophage chemokine and cytokine secretion and nuocyte cytokine secretion are 
important links between the innate and adaptive responses.4,18 
 
 
 
 
 
Figure 1.1 Macrophage precursors are released into the circulation from the bone marrow 
as monocytes. They migrate into nearly all tissues where they differentiate into specialized 
tissue specific mature macrophages. Various subsets are distributed at strategic locations 
around the body and perform immune surveillance, antigen presentation, immune 
regulation, clearances of cellular debris and tissue remodelling. (Image from Murray & 
Wynn, 2011) 
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1.4.2 Antigen presentation 
Antigen presentation by MHCI (Major Histocompatibility Complex I, HLA molecules in 
humans) molecules in mice occurs on most nucleated cells. A sample of all self peptides 
produced in the endoplasmatic reticulum (ER) is loaded onto MHCI molecules and 
transported to the surface of the cell. This allows for the differentiation between self and 
non-self. Since viral infections are always intracellular and the virus makes use of the ER to 
produce its proteins, MHCI molecules also present viral peptides and therefore signal virally 
infected cells.1 Antigen presentation by MHCII molecules occurs by APCs only. APCs are also 
phagocytes. Internalization of the pathogen or foreign complex protein is followed by its 
degradation into peptides in the phagolysosome and loading of the foreign peptide onto an 
MHCII molecule which then moves to the surface of the cell and signals to T cells of the 
adaptive response.1  
 
1.4.3 Induction of the adaptive response 
Naive T cells require two signals to be fully activated: cognate interaction with MHCI or 
MHCII molecules complexed to foreign peptides and the engagement of costimulatory 
molecules expressed on APCs, such as  CD80 and CD86, with receptors on T cells, such as 
CD28  (Fig 1.2).18  Thus antigen pre entation by innate cells functions to 1) alert the adaptive 
response that clonal expansion of antigen-specific cells is required to control the infection 
and 2) to instruct it on the nature of the pathogen and the type of adaptive response that is 
required. 
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Figure 1.2 T cell activation requires two signals. (A) CD8+ and CD4+ T cells recognize 
antigen through their T cell receptors (TCR) binding to peptide antigen presented on MHCI 
and MHCII molecules, respectively. (Germain, 2002) (B) Naive T cells are activated by TCR 
recognition of antigen:MHC complexes on antigen presenting cells (APCs) and cognate 
interaction of CD28 with co-stimulatory molecules CD80 or CD86. If costimulation does not 
occur, the T cell undergoes apoptosis or anergy. (Alegre et al., 2001) 
 
1.5 Adaptive Immunity 
1.5.1 Lymphocytes and their antigen receptors 
Lymphocytes are cells of the adaptive response and are primarily composed of T and B cells. 
Both originate in the bone marrow. T cells mature in the thymus whereas B cells mature in 
the spleen. T cells poses TCRs on their cell surfaces which recognize antigen bound to MHC 
molecules (Fig 1.2 A), and, along with costimulatory receptor binding, activate the cell (Fig 
1.2 B). B cells possess BCRs (B cell receptors) which are surface immunoglobulins and bind 
antigen directly, internalize the antigen by phagocytosis and present it on MHC molecules. 
TCRs and BCRs are assembled from called the Variable, Diverse and Joining  gene segments 
by a process called V(D)J rearrangement in the central lymphoid organs (thymus and bone 
marrow). The binding cleft of these receptors (encoded by the Variable gene segment, and 
forming the “variable region” of the receptor) is encoded by many different genes which 
allows the formation of a diverse set of receptors and the recognition of a large variety of 
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antigen or antigen:MHC complexes.1 TCRs and BCRs are essential to T and B cell survival, 
respectively, in their primary lymphoid organs of origin as well as in the periphery where it is 
thought that they both receive essential positive signals through low affinity binding of self 
antigen to their receptors.19 
 
1.5.2 Tolerance induction 
While cells of the innate system differentiate between self and foreign antigen by the 
germline encoded specificity of their PRRs, lymphocyte receptors undergo somatic 
hypermutation throughout the lifetime of the organism to adapt to the wide variety of 
antigen they encounter, however receptor specificity must not be directed against self 
antigen with high affinity. Lymphocytes undergo checkpoints during maturation to eliminate 
self-reactive T and B cells and prevent autoimmunity, a process called tolerance induction. T 
cells undergo two checkpoints of positive and negative selection during maturation in the 
thymus, mediated through TCR recognition of antigen:MHC complexes. A positive signal is 
provided by the binding of the TCR to self antigen:MHC complexes on thymus stromal cells 
and is required for T cell survival.19 However, this signal must be weaker than that needed to 
activate a mature T cell with the same TCR, i.e. the binding must be of low affinity.20 This is 
thought to be primarily required to ensure MHC restriction, that T cells only respond to 
antigen bound to the host’s own MHC molecules.21 TCRs that recognize self antigen:MHC 
complexes with high affinity are removed by clonal deletion during negative selection.22  
 
Less is known about B cell tolerance induction. Two maturation checkpoints have been 
identified and these are both negative selection: a central checkpoint in the bone marrow 
and a peripheral checkpoint in the spleen.23 B cells whose BCRs recognize self antigen with 
high affinity (to a multivalent antigen) either undergo receptor editing and/or clonal 
deletion, or if recognition is with low affinity (to a soluble, monovalent antigen), the B cell 
becomes anergic (discussed in more detail below).24,25 Partly because BCRs recognize 
antigen directly and are not dependent upon MHC molecules on APCs, it has been difficult 
to determine and is yet unclear whether B cells undergo positive selection like T cells do.26 
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1.5.3 T cells 
T cells have many subsets but the better characterized effector cells are CD4+ helper T cells 
and CD8+ cytotoxic T cells. They are MHCII and MHCI restricted, respectively  (Fig 1.2A).27 
Following activation, helper T cells stimulate antibody production by B cells and increased 
efficiency of innate responses, such as increased killing of pathogens by phagocytes.28 CD8+ 
cytotoxic T cells, following activation, destroy cells infected by intracellular pathogens like 
viruses by inducing them to undergo apoptosis and thereby containing the infection. 
Importantly, cytotoxic T cells typically induce apoptosis, as opposed to necrosis, which 
largely contains intracellular pathogens. Helper T cells are important in Salmonella and 
helminth infections and will be discussed in greater detail.19 
 
1.5.3.1 CD4+ T helper 1 vs. T helper 2 
After activation or “priming”, helper T cells start to proliferate and acquire effector 
characteristics. Helper T cells differentiate into one or more functionally distinct subsets and 
acquire the capacity to interact with B cells in secondary lymphoid organs and activate 
different immune mechanisms to eliminate the pathogen.29 The subset that gains 
predominance is determined by 1)  the type  of APC presetting the antigen, 2) the co-
stimulatory molecules, 3) the nature and dose of the pathogen and 4) the immediate 
cytokine environment experienced by the T cells at the time of antigen presentation.30 
 
Two major subsets of the helper T cell response are the T helper cell 1 (Th1) and T helper 
cell 2 (Th2) response, characterized by the cytokine profile they produce and, in mice, the 
switched antibody isotype they induce in B cells (Fig 1.3). Th1 responses induce the 
phagocyte-dependent host response to most intracellular pathogens. The cytokine 
interleukin-12 (IL-12), produced initially by APCs and particularly by macrophages, is the 
predominant cytokine that induces Th1 differentiation. Binding of IL-12 to its receptor on 
primed helper T cells  results in signalling through the STAT-1 pathway and upregulation of 
the transcription factor T-bet.31  Th1 cells then upregulate the IL-12 receptor (IL-12Rβ2) and 
release high levels of cytokines interferon gamma (IFNγ), IL-2 and tumour necrosis factor 
beta (TNF-β). This promotes the activation of macrophages, antibody-dependent CD8+ T cell  
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Figure 1.3 CD4+ T helper cell polarization into various effector subsets and the cytokines 
that induce them. Activation of naive CD4+ T helper cells in response to a particular 
inflammatory environment results in the polarization into a specific subset of effector T 
cells. They are defined by their expression of transcription factors, effector profile of 
cytokine secretion and activation of the adaptive response to clear the infection. Two such 
subsets are Th1 and Th2 cells which respond to intracellular and large extracellular 
pathogens, respectively, and oppose each other’s functions. Other subsets include Th17, 
Treg and Tfh subsets. (Image adapted from Jelly-Gibbs et al., 2008) 
 
cytotoxicity and delayed type hypersensitivity (DTH), as well as the stimulation of B cells to 
produce IgG2a opsonizing and complement-fixing antibodies.32 Signalling through the STAT-
4 pathway via the IL-12Rβ2 also stimulates expression of IFNγ and the IL-18 receptor, 
creating a positive feedback loop. 
 
Th2 responses are humoral and phagocyte-independent, and necessary for the expulsion of 
extracellular pathogens such as helminths (e.g. Nippostrongylus brasiliensis).33,34 In allergic 
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reactions, however, a harmful, exaggerated Th2 response is elicited against seemingly 
harmless antigens in genetically predisposed individuals which could lead to anaphylactic 
shock and death.35 Th2 responses are now known to be initiated by the secretion of IL-25 
and IL-33 cytokines from epithelial cells which activate innate nuocytes via their T1/ST2 
receptor (a member of the TLR IL-1R). Nuocytes then produce the polarizing T cell cytokine 
IL-4.36 IL-4 binding to IL-4Rα on primed helper T cells induces Th2 differentiation via 
signalling through the STAT-6 pathway and upregulation of the transcription factor GATA-
3.37 The T1/ST2 receptor has also been found on eosinophils and basophils,36 which, along 
with the non-conventional innate-like γδ T cell subset, NK T cells and mast cells, also 
produce the polarizing cytokine IL-4.38 Th2 cells then secrete predominantly IL-4 and IL-13, 
but also IL-5, IL-6, IL-9 and IL-10 and provide optimal help to B cells in the spleen to induce 
their switching to IgE and, in mice, IgG1.39 Th2 responses also include eosinophilic 
inflammation, mast cell proliferation, goblet cell hyperplasia and excessive mucous 
production at mucosal surfaces. The details of Th2 response to helminths are discussed in 
Section 2.11.1 in Chapter 2. 
 
Th1 and Th2 effector responses counter regulate each other. The IL-12 produced by a Th1 
response suppresses Th2 polarisation and IL-10 blocks Th1 cells developing. This occurs at 
the signalling and genetic levels, where Th2 associated GATA-3 opposes Th1 associated 
STAT-1 signalling by blocking IL-12Rβ2 expression, whereas STAT-1 downregulates GATA-3 
expression.40 
 
1.5.3.2 Other CD4+ T cell subsets 
The Th1/Th2 paradigm does not cover all helper T cell responses and there are other 
subsets which perform specific functions along with Th1 or Th2 cells (Fig 1.3).  Th17 cells, 
stimulated by IL-6 to produce IL-17, aid in immunity to extracellular bacteria, particularly on 
mucosal surfaces.41 Found in the gut, Th17 cells are activated by specific commensal 
bacteria can promote their differentiation.42 A major function of helper T cells is to help 
stimulate B cells to produce antibody to T-dependent antigens. A subset called T follicular 
helper (Tfh) cells reside in B cell follicles in secondary lymphoid organs and specifically enter 
the germinal center. Here they mediate their function by producing IL-4 and IFNγ, but no 
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other signature cytokines, to help B cells generate antigen specific antibodies.43 An 
important subset of T cells that regulates and prevents over-activity of the inflammatory 
response to protect host tissue from damage is the regulatory T cells (Tregs). Treg are 
CD4+CD25+FoxP3+, cause immuno-suppression and are induced by IL-10.41 Deficiency in 
Tregs results in lethal multi-organ autoimmune syndrome and a hyper-reactivity to 
commensal bacteria.44,45 
 
1.5.4 B cells 
Mature B cells can be divided into distinct subsets which respond to T-dependent and T-
independent antigens and are designated: conventional B2 B cells which comprise follicular 
(FO) B cells found in the follicles of secondary lymphoid organs and marginal zone (MZ) B 
cells found only in the spleen, as well as B1 B cells which comprise B1a and B1b B cells found 
in the peritoneal and pleural cavities and the gut lamina propria (Fig 1.4). 
 
1.5.4.1 Antibodies 
As discussed, B cells function to present antigen and secrete cytokines, but their main 
function is the production and secretion of antigen specific antibodies, also called 
immunoglobulins (Ig), of different isotypes (IgM, IgA, IgG1, IgG2a, etc.). Antibodies 
neutralize the effect of a pathogen or a toxin through binding to its surface and preventing it 
from entering the host cell or causing damage to cells and tissues. Antibodies can also 
opsonize pathogens to enhance their recognition and destruction by phagocytes46 or 
facilitate their destruction by a mechanism called is Antibody-Dependent Cell-Mediated 
Cytotoxicity (ADCC).47 Less prominent in mice and more relevant in cancer therapy, ADCC 
functions by NK T cells and eosinophils destroying antibody-coated cells without 
phagocytosis by the release of lysis products.47 Another mechanism antibodies use is to 
activate complement proteins to attack and destroy antibody coated cells.48 The specificity 
of the antibody produced by a B cell is the same as its surface Ig or BCR. 
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Figure 1.4 Hierarchy of B cell populations, their surface expression of receptors and TD or 
TI response to antigen types. B2 B cells represent the largest proportion of adult B cells and 
are subdivided into follicular and marginal zone B cells which respond to TD and TI antigens 
respectively. FO B cells can undergo affinity maturation in a germinal centre reaction in 
response to antigen which results in high affinity antibody secreting memory B cells and 
long- and short-lived plasma cells. Marginal zone B cells are stimulated by TI-2 antigens and 
form IgG3 secreting short-lived plasma cells. B1 B cells are differentiated from B2 B cells by 
their unique surface markers, anatomical location and their ability to self-renew. B1a B cells 
respond to TI-1 antigens and form IgM and IgA secreting plasma cells, as well as natural IgM 
antibodies. The function of B1b B cells is unknown but they are important in the TI response 
to relapsing fever caused by Borrelia hermsii. MZ and B1a B cells are the first to respond to 
infection, giving FO B cells time to form germinal centres and produce high affinity antibody 
producing cells (APCs). BM: bone marrow, TD: T-dependent, TI: T-independent. 
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1.5.4.2 B cell maturation 
Before birth, B cells develop in the fetal liver from pluripotent hematopoietic cells24 and, as 
described in section 1.5.1, in the bone marrow after birth. B2 B cells (also called 
conventional B cells) then migrate to the spleen where they mature. B1 B cells, on the other 
hand, are innate-like B cells and complete their maturation on the bone marrow during the 
neonatal period. They are found in the peritoneal and pleural cavities but can migrate to the 
spleen, mesenteric lymph nodes and gut associated lymphoid tissues.49 
 
Bone marrow development is called central B cell development and generates immature, 
BCR expressing B2 cells (from now on referred to as B cells) called newly-formed or 
transitional-1 (NF/T1) B cells. The development of B cells can be tracked based on the 
surface expression of various receptors (Fig 1.4, Table 1.1).  NF/T1 B cells express high levels 
of early markers CD24, CD93 (also referred to as AA4.1) and surface IgM, very low levels of 
CD21 and have yet to acquire the B cell markers IgD and CD23 (and are therefore 
CD24hiCD93hiIgMhiCD21-/loIgD-CD23-).50  NF/T1 B cells enter the splenic follicles where they 
upregulate expression of IgD and mature into T2 B cells which can be divided into two 
separate populations, based on their subsequent lineage decision.51 T2-FP B cells are the 
precursors to follicular (FO) B cells, are present in all secondary lymphoid follicles and are 
CD21int. T2-MZP cells are the precursors to marginal zone (MZ) B cells, are only seen in the 
spleen and are CD21hi (complement binding receptor).51 Both T2 populations are CD23+. T2-
FP B cells mature further into mature FO B cells, a highly differentiated population which 
loses expression of the early markers and is now CD23hiCD21intIgMloIgDhi. T2-MZP B cells 
become mature MZ B cells that are CD1dhiCD23-IgMhiIgDlo.26 The signals that control 
maturation into FO or MZ B cells include BCR signalling,52 cognate interactions with and co-
stimulation by T cells,53 and antigen dependent selection.50 
 
Few transitional B cells become mature, long-lived B cells. Out of the 2x107 IgM+ B cells that 
develop daily in the bone marrow of the mouse, 10% reach the spleen and only 1–3% enter 
the mature B cell pool.52 Mature FO and MZ B cells, now ready to become activated by 
stimulating antigen, respond to different types of antigen, require different activation 
signals and have different types of antibody responses. 
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Table 1.1 B cell receptors that are used to differentiate different B cell populations. 
Expression of surface receptors changes throughout B cell maturation, differentiation, 
antigen stimulation and interaction with T cells. These receptors are used as markers to find 
specific B cells by flow cytometry and immunohistochemistry. CAM: cell adhesion molecule. 
 
 
1.5.5 T-dependent vs. T-independent antibody responses 
Nearly all protein antigens require cognate interaction between helper T cell and B cell 
along with stimulation of the BCR in order to initiate antibody responses, and are called 
Thymus-dependent (TD) antigens. Some non-protein bacterial antigens, such as capsular 
polysaccharides, are able to elicit an antibody response in nude mice, i.e. in the absence of T 
B cell 
marker
  Cell type  Function    aka     Reference
B220
All B2 cells with diffuse levels of 
expression, excpet plasma cells
Co-stimulation CD45R
Hardy and Hayakawa 
(1991)
CD19
All B cells except B1 B cells; low 
expression on plasmablasts
Co-receptor; part of BCR complex, 
regulating the BCR signal
- Engel et al. (1999)
CD21 Highly expressed on MZ B cells
Complement receptor 2; binds 
variations of C3 protein as a co-
receptor when complexed to CD19 
and CD81
CR2
Zandvoort and 
Timens (2002)
CD23 Highly expressed on FO B cells
FcεRII: low affinity receptor for IgE; 
binds IgE immune complexes
FcεRII
Palanichamy et al. 
(2009)
CD93
Transtional B cells; re-expressed 
late in differentiation on PCs
Cell adhesion molecule (CAM); 
involved in clearance of apoptotic 
cells and survival of long-term PCs in 
the bone marrow
AA4.1 Malissen et al. (2009
CD24 Transitional B cells, GC B cells CAM; associated with tumour cells HSA
Loder et al. (1999); 
Shinall et al. (1950)
IgM
Transitional B cells, MZ B cells, 
B1 B cells
BCR -
Hardy et al. (2001); 
Su et al. (2004)
IgD Highly expressed on FO B cells BCR -
Hardy et al. (2001); 
Su et al. (2004)
CD95 GC B cells Induces apoptosis
Fas receptor; 
death receptor
Kondo et al. (2007)
GL7 GC B cells B cell activation - Naito et al. (2007)
PNA GC B cells
Binds carbohydrate sequence  Gal-
β(1-3)-GalNAc
- Coico et al. (1983)
CD27 Memory B cells and plasma cells
Part of the TNF receptor family; 
regulates B cell activation and Ig 
synthesis
-
Borst et al. (2005); 
Jacobi et al. (2010); 
Qian et al. (2010)
CD138
Plasma cells (but not all plasma 
cells)
Cell migration; cell adhesion; cell 
proliferation; internalization of HIV-1 
tat protein
Syndecan-1 
(SDC1)
Qian et al. (2010)
CD5 B1a B cells
Negatively regulates the BCR signal 
to prevent autoimmunity
- Berland et al. (2002)
B cell marker 
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cell help, and are called Thymus-independent (TI) antigens.54 TI antigens have been sub-
classified into: Type-I (TI-1 antigens) and Type-II (TI-2 antigens) which activate B cells by 
different mechanisms.55 Naive mature B cell antigen activation occurs in secondary 
lymphoid organs, the spleen being the most highly organized tissue optimal for B cell 
stimulation with antigen, interaction with T cells and splenic APCs. 
 
1.5.5.1 Spleen microarchitecture 
The spleen is the largest secondary lymphoid organ and contains about one fourth of the 
body’s lymphocytes, initiating immune response to blood-borne antigen. The spleen 
comprises mostly red pulp which contains splenic macrophages that phagocytose aged or 
dead red blood cells and opsonized blood-borne microbes.56 Interspersed amidst the red 
pulp are discrete areas of lymphoid white pulp. The white pulp is arranged in specialized 
layers of cells around a central arteriole (CA) that brings lymphocytes and antigen to the 
spleen. These layers comprise the periarteriolar lymphoid sheath (PALS), the follicles and 
the marginal zone (Fig 1.5).57 The marginal sinus separates the follicle and the marginal zone 
and is where blood-borne antigen enters the tissue.56  
 
The PALS contains mostly CD4+ T cells in the T zone, with macrophages around its edges, 
interdigitating DCs and migrating B cells and is the site of CD4+ T cell interaction with 
antigen presenting DCs. The follicle is continuous with the PALS and mainly consists of FO B 
cells surrounded by a etwork for follicular DCs (FDCs) and some macrophages.57 The 
marginal zone lines the boundary between the white and red pulp and contains mainly MZ B 
cells and also MZ macrophages and marginal metallophillic macrophages (MMMs). Full 
development of the MZ B cells and the marginal zone is delayed until about 3-4 weeks after 
birth in rodents and 2 years in humans.51 The organization of the white pulp of the spleen is 
similar to that of a lymph node, but while the spleen detects blood borne antigens, lymph 
nodes detect tissue localised antigens in draining lymph fluid. 
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Figure 1.5 The microarchitecture of the spleen showing B cell maturation from the bone 
marrow. The spleen is highly organized to allow optimal stimulation of B cells with antigen 
and interaction with helper T cells and APCs to promote antibody production via TD and TI 
responses. Amidst the red pulp are discrete areas of lymphoid tissue, called white pulp, 
found in layers surrounding a central arteriole (CA). The periarteriolar lymphoid sheath 
(PALS) comprises mostly T cells in the T zone but also some B cells and macrophages, and is 
an important site for lymphocyte trafficking. Immature transitional-1 (T1) B cells coming 
from the bone marrow enter the splenic white pulp from the CA into the PALS. Continuous 
with the PALS or T zone are the B cell follicles where T1 B cells mature to T2 B cells and then 
to follicular (FO) B cells. FO B cells are mobile and constantly migrate to and from B cell 
follicles in secondary lymphoid organs around the body.  T2 B cells also mature into marginal 
zone B cells (MZ) which make up the marginal zone surrounding the follicles and the PALS 
and separating the white pulp from the red pulp. Between the marginal zone and the 
follicles is the marginal sinus (not shown here) where blood-borne antigen enters the white 
pulp and is captured by marginal zone macrophages and macrophages lining the outer PALS. 
(Su et al., 2004) 
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1.5.5.2  T-dependent antibody responses 
Naive FO B cells represent the largest proportion of the adult B cell population. They are in a 
constant state of migration between the follicles of secondary lymphoid organs.58 Migration 
ceases if the B cells are recruited into an antibody response.  Protein antigens stimulate 
antibody responses from FO B cells to form highly specialized, transient germinal center 
(GC) reactions in follicles which are the source of high affinity antigen specific plasma cells 
and memory B cells. This process is initiated at the boundary between primary follicles 
(follicles without GCs)  and the T zone where rare B and T cells specific for the same antigen 
are primed by antigen presented on interdigitating DCs.59 FO B cells then migrate into the 
follicle where they undergo massive clonal expansion and somatic hypermutation of their Ig-
variable-regions where the variable region of the BCR is further diversified by point 
mutations.60 These cells form the germinal center (GC) and, as the GC matures, separate 
into the dark and light zones (Fig 1.6).  
 
The dark zone is oriented towards the T zone and comprises tightly packed centroblasts 
undergoing rounds of replication, somatic hypermutation and antibody class switching.56 
The centroblasts then stop dividing and bec me small centrocytes which undergo selection 
in the light zone based on the affinity of their surface antibody (BCR) to the inducing 
antigen. Screening for self-reactive B cells also occurs in the light zone and these B cells 
undergo apoptosis. All apoptotic B cells in the GC are phagocytosed by tingible body 
macrophages.60 The light zone, strategically oriented towards the marginal sinus and the 
source of foreign antigen in the spleen,61 also contains a rich network of FDCs which are 
distinct from FDCs found in primary follicles.59 These FDCs have the capacity to take up 
antigen and retain it for periods of over a year. This antigen can be taken up by a centrocyte 
through its BCR, internalized, processed and presented on its MHCII molecules to Tfh cells 
which recognizes it. In this process of linked recognition, the B and Tfh cells are specific for 
the same antigen and the B cell receives two signals which select it: antigen recognition 
through its BCR and co-stimulation by interaction between CD40L on the Tfh cell and CD40 
on the B cell.60  
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Figure 1.6 Germinal centre cell types and events. (A) Germinal centres (GCs) develop within 
B cell follicles and are seeded by a small number of activated B cells. B cells and T follicular 
helper (Tfh) cells specific for the same antigen establish stable interactions at the boundary 
between the T zone and the follicle and enter follicles, receiving survival signals. GC B cells 
proliferate and displace naive FO B cells, forming the two zones of the GC: the dark zone and 
the light zone. The dark zone contains densely packed, highly proliferative centroblasts 
undergoing rounds of somatic hypermutation (SHM) in their immunoglobulin variable 
regions. The light zone is full of follicular dendritic cells (FDCs) that bind and present antigen 
in the form of unprocessed immune complexes. Once they stop dividing, centroblasts move 
to the light zone where they are called centrocytes and are selected based on their affinity 
for antigen presented by FDCs and their cognate interaction with Tfh cells. Low affinity and 
self-reactive B cells undergo apoptosis and are phagocytosed by tingible body macrophages. 
Selection can lead to terminal differentiation into memory B cells or plasma cells. (Vinuesa 
et al. 2009) (B) Immunohistochemical staining of splenic white pulp: CD3 stains the T cells in 
the T zone (T) in blue and IgD stains the B cells in the follicles (F) in brown with unstained 
IgD- germinal centres (GC) within the follicles. (Bobat, 2011) (C) Enlarged view of GCs 
showing the T zone in blue, follicles in brown. Within the GC, proliferating centroblasts 
within the dark zone of the GC are stained in pink with BrdU and the centrocytes in the light 
zone are unstained. Staining of the same spleen section with FDC-M2 shows the dense FDC 
network within the light zone of the GC. (Allen et al., 2004) 
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1.5.5.3 High affinity plasma cells and memory B cells 
Positively selected GC B cells are antigen specific with high affinity. A proportion of these 
cells moves to the red pulp and differentiates into memory B cells, plasmablasts and short-
lived plasma cells. While plasmablasts and plasma cells both secrete large amounts of 
antibody, plasmablasts can still proliferate whereas plasma cells have stopped proliferating. 
Short-lived plasma cells disappear from the spleen within two weeks of infection.62 The 
survival of long-lived plasma cells is ensured by the survival niche in which they reside. 
When activated by antigen, memory B cells can become plasmablasts which can in turn 
become long-lived plasma cells. Plasmablasts and plasma cells may migrate to the inflamed 
tissue, the bone marrow or the red pulp of the spleen. All three tissues provide plasma cell 
survival niches. However, once the infection and tissue inflammation has been resolved, 
these cells die by apoptosis.63 Most long-lived plasma cells end up in the bone marrow 
where they become immobile and can survive for up to a year and account for long-term 
antibody production and humoral memory.63 
  
In TD responses, activated FO B cells can also become plasmablasts which move to the red 
pulp and form plasma cells. This occurs without GC formation and is termed extra-follicular 
antibody response.58 
  
1.5.5.4 T-independent antibody responses 
Unlike TD antigens, TI antigens can directly induce B cell proliferation as the second signal 
can be provided by the antigen itself.1 MZ and B1 B cells respond to TI antigens in the 
absence of T cell help and GC reactions and are the first to respond to foreign antigen.58 B1a 
B cells constitutively produce natural IgM  without exposure to any environmental antigen58 
but can respond to TI-1 antigens like LPS which trigger innate receptors on B cells.64 These 
receptors are skewed towards common bacterial antigens and do not undergo somatic 
hypermuation.65 They do, however, migrate to the spleen upon activation where they 
differentiate into plasma cells upon antigen encounter. B1a B cells also produce antigen 
specific IgA in the lamina propria of the gut and play an important role in host defence at 
mucosal surfaces.64 B1a B cells are self-renewing, which B2 FO and MZ B cells are not. The 
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function of B1b B cells is not clear, although they are important in the TI response to 
relapsing fever caused by Borrelia hermsii.66 
 
MZ B cells are non-circulating B2 B cells found, in mice, only in the splenic marginal zone and 
respond to TI-2 antigens which typically include polysaccharide chains of repetitive 
sequences like bacterial LPS. These antigens crosslink many BCRs on the same B cell and 
induce a proliferative antibody response.51 Interestingly, MZ B cells in humans recirculate 
freely and are identical to somatically hypermutated IgM+ memory B cells.51 MZ B cells 
respond to TI antigens by differentiating into low-affinity extra-follicular plasma cells which 
produce germ-line encoded antibodies, the main isotype being IgG3 in mice and IgG2 in 
humans.55 TI responses are essential in response to non-protein antigen and they provide 
immediate protection with broad specificity antibodies. Two days after immunization with 
TI-2 antigens, foci of plasmablasts are seen along the periphery of the PALS, expanding until 
8 days post immunization after which they diminish and die by apoptosis.62 Only 10-14 days 
post immunization is enough T cell help is recruited in a TD, GC response.62 Thus the TI 
response is an innate-like antibody response which holds the fort until the adaptive TD 
response kicks in against the same infection (since microbes have many antigenic 
molecules). However, little is known about the mechanism by which TI responses are 
activated and regulated. 
 
1.6 Neonatal Immunity 
In humans the neonatal period is defined as the first 28 days after birth. The human 
neonatal immune system is fully developed at birth but represents a unique and highly 
plastic but weak period of immune defence, different to that of adults in humoral and cell-
mediated immunity.67 Due to lack of immune memory, newborns are highly sensitive to 
pathogens and infectious disease is a major cause of human infant mortality in developing 
countries and hospitalization in industrialized countries. Each year more than 2 million 
children aged between 1 and 6 months die due to respiratory infections or diarrheal 
disease. Early life infections like influenza and respiratory syncytial virus (RSV) and bacterial 
infections account for a significant proportion of infant hospitalizations.68,69  
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Many of these diseases should be preventable by already available vaccines. However, only 
three vaccines are currently given at birth: oral polio vaccine (OPV), hepatitis B virus (HBV) 
vaccine and bacille-Calmette Guerin (BCG) and, with the exception of BCG, require several 
booster immunizations.68 Young infants (<3 months) are incompletely protected by vaccine 
schedules with pertussis vaccines which are initiated too late, no influenza vaccine is 
licensed for the use prior to the age of 6 months and there is no licensed RSV vaccine.68  
So far, strategies to protect neonates and young infants against overwhelming infections 
have included indirect protection via maternal vaccination, cocoon strategies where people 
in contact with the neonate are vaccinated to prevent spread of disease, or direct neonatal 
vaccination. Concerns regarding neonatal immune tolerance to vaccine antigens and 
unpredictable adverse effects arising from an immune system that does not respond like 
that of an adult, have hindered the development of neonatal immunizations. However, 
recent advances have revealed much about this unique period of immune response and 
show various potential strategies for the development of neonatal vaccines. 
 
1.6.1 A Th2 biased immune system  
A successful pregnancy requires the maternal endometrium to accept invasion and 
infiltration of semiallogenic feto-paternal DNA and RNA. This type of invasion normally 
induces Th1 repose as in viral infections. In order for the maternal immune system to accept 
the fetus as an allograft and not destroy it by mounting a Th1 cytotoxic response, the 
maternal-fetal interface  requires a suppression of the maternal inflammatory response.70 
This is brought about by the production of Th2 cytokines and repression of Th1 cytokines, 
largely by the placenta (Fig 1.7). Proinflammatory Th1 cytokines like IFNγ and TNFα promote 
expression of the pro-apoptotic transmembrane protein, Fas, and thereby the sensitivity of 
the trophoblast cells to apoptosis. Regulatory Th2 cytokines like IL-6 and IL-10, on the other 
hand, repress Th1 cytokines and activation of NK cells and macrophages, promoting the 
implantation and maintenance of the trophopblast.71,72 Studies in mice have shown that 
fetoplacental tissue spontaneously secretes Th2 cytokines, and that a Th2:Th1 ratio of 
cytokine production was greater than that of restimulated maternal splenic cells.73 Thus a 
normal pregnancy requires a Th2 biased environment to avoid loss of the trophoblast. This 
regulatory immune imbalance that protects the fetus in utero is passed onto the fetus itself 
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and extends into the neonatal period.70 The neonatal immune system is therefore not under 
developed or immature at birth but, rather, specifically adapted for survival in utero. After 
birth the neonate encounters a new world of pathogens, many of which are viruses and 
bacteria. With a mostly antigen inexperienced immune system that is biased against a Th1 
response, neonates are highly susceptible to viral and bacterial infections.68 
 
1.6.2 Neonatal innate and adaptive immunity 
Although the human neonatal immune system is fully developed at birth, it responds weakly 
to vaccination and infection due to an antigen inexperienced adaptive response. However, 
adult-like B and T cell responses have been demonstrated under specific conditions and 
stimulations, displaying the plastic nature of the neonatal immune system. Due to lack of 
antigen encounter and pre-existing immunological memory, the concentrations of soluble 
mediators, absolute numbers of immune cells, their ratios and activation states differ from 
those of adults.74 
 
1.6.3 Neonatal antigen presentation 
Neonatal APC-T cell interactions are sub-optimal and could contribute to the Th2 biased 
neonatal immune response. Dendritic cells are the most important APCs for stimulating 
naive T cells. Once activated, T cells provide help to B cells for antibody production. 
Moreover, DCs produce various factors, such as IL-12, which polarize CD4+ T cells to a Th1 
type response (Fig 1.7).75 Absolute numbers of neonatal mouse DCs are reduced by several 
logs compared to adults.  The splenic T cell to DC ratio reaches adult proportions by 1 week 
after birth yet seems to be functionally immature in some settings.76 This immaturity has 
been attributed to low expression of costimulatory molecules and IL-12. As with neonatal T- 
and B cells, under certain circumstances neonatal DCs are capable of mature response. In 
humans, cord blood mononuclear cell (CBMC)-derived DCs express limited IL-12 and IL-1577 
which seems to persist for up to 1 year after birth.78 Optimal APC function is thus a key 
element for overcoming the Th2 biased neonatal immune response and eliciting an adult-
like Th1 response. 
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Figure 1.7 The development of the neonatal innate nd adaptive immune responses with 
time. Maternal T cell tolerance induction of the trophoblast is required for survival of the 
fetus. This is achieved by repression of intrauterine Th1 responses and induction of a Th2 
environment and is passed onto the fetus. Humans display high proportions of Tregs and NK 
T cells at birth. Adaptive immune functions (top panel): maternal IgG is transferred in utero 
during late gestation, followed by human milk IgA (and some IgG) through breastmilk. The 
infant’s own antibody (T-dependent, but especially T-independent) and T/B cell memory 
responses become fully mature later during early childhood. Innate immune functions 
(bottom panel): Pro-inflammatory Th1 and Th17 inducing cytokines (IFN-α, IL-1β, IL-6, TNF-
α, IL-12 and IL-23) are attenuated in neonates, whereas anti-inflammatory IL-10 is relatively 
high during the late gestational phase. Phagocyte function develops fully in early childhood. 
(Sharma et al., 2012) 
 
1.6.4 Neonatal complement proteins 
Complement plays an important role in both innate and adaptive responses. Human79 and 
mouse80 infants have low levels of serum complement component C3, which, along with a 
deficiency in CD21 on B cells, impairs formation of C3d-antigen complexes and localization 
on MZ B cells, thereby limiting activation of the alternative pathway to polysaccharide (T-
independent) antigens.  
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1.6.5 Maternal antibodies 
Neonates and infants display a limited ability to generate primary antibody responses. 
Vaccination of infants is thus only partially successful but crucial in protecting the highly 
susceptible newborn. Maternal antibodies (MatAb) account for some protection for the first 
3 to 12 months after birth, and pregnant women in developing countries are vaccinated in 
order to transfer protective IgG to their babies. With weaning and the decay of MatAb, a 
window period occurs where the infant is left unprotected before its adaptive response is 
fully matured (Fig 1.8).  
 
 
 
Figure 1.8 Passive protection of neonates and young infants by maternal antibodies 
before the adaptive response develops. Maternal antibodies are transferred in utero and 
via breastmilk and protect neonates from early infections. Breastmilk antibodies and 
transferred antigen in the form of maternal antigen and food antigen help to colonize the 
neonate’s gut and induce oral tolerance. Before the adaptive response is fully matured and 
once maternal antibodies wane, the infant enters a window period where it is left 
unprotected. (Butler et al., 2009) 
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Paradoxically, MatAb are known to interfere with primary antibody responses to 
immunizations in infants.81,82 By epitope masking, antigen specific MatAb bind to vaccine 
antigens in an epitope-specific manner and prevent infant B cells from accessing 
immunodominant vaccine epitopes for recognition by their BCRs and activation of a 
functional primary antibody response (Fig 1.9).83  MatAb mediated inhibition is titre 
dependent and has the capacity to be circumvented by increasing the dose of vaccine 
antigen. This epitope-specificity of MatAb-mediated inhibition has not been shown or 
reported in human infants, only in mice,84 although supporting evidence has been seen with 
the HIB-conjugate vaccine. MatAb specific to the protein carrier (i.e. TT) inhibit infant 
responses to TT, but do not inhibit infant response to the HIB polysaccharide moiety of the 
vaccine.85 Another proposed mechanism of MatAb-mediated inhibition is the mopping up of 
vaccine antigen by the uptake of MatAb:antigen immune complexes by neonatal APCs (Fig 
1.9).83 
 
While MatAb prevent B cell priming due to a common antigen epitope specificity, MatAb do 
not influence T cell priming since TCRs recognize different epitopes on the vaccine antigen.84 
This has been shown in mice and evidence from clinical studies where MatAb-inhibition of 
primary responses did not inhibit a priming, i.e. a T-dependent secondary response after 
booster immunization, suggest that this is the case in human infants.83 
 
1.6.6 Neonatal B cells 
Human infants have higher counts of total B cells than adults, increasing in the first weeks of 
life and remaining high for the first year of life.86 There are numerous phenotypic and 
functional differences between neonatal and adult mouse splenic B cells, but fewer when 
comparing neonatal and adult peripheral B cells. Immature transitional (IgMhiIgDlo/-) B cells 
dominate in the neonatal mouse spleen and fail to upregulate co-stimulatory molecules and 
MCHII upon ligation of their BCR, essential for effective interaction with T cells.67,87 Neonatal 
splenic B cells have limited expression of CD21,88 CD40, CD80, CD86 and limited interaction 
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Figure 1.9 Influence of passively transferred maternal antibodies on induction of vaccine 
responses in offspring. MatAb can inhibit B cell priming of infants and thereby prevent 
infant production of their own humoral response to vaccinations. Two mechanisms may 
account for this inhibitory effect: 1. The masking by MatAb of immunodominant epitopes on 
the vaccine antigen and blocking access to infant B cells, and 2. The mopping up of 
MatAb:antigen immune complexes by infants APCs. The latter mechanism does not 
influence B cell antigen presentation to T cell as the APC is still able to present antigen. 
However, T and B cells recognize different antigen epitopes and therefore T cell responses 
are thought to be largely unaffected by MatAb (Image adapted from Siegrist, 2001). 
 
with ligands such as B cell activating factor (BAFF) and/or proliferation-inducing ligand 
(APRIL), all of which are plasma cell supporting factors.89  
 
1.6.6.1 Neonatal germinal centres 
Neonates have impaired GC formation.  In humans, GCs only appear at about 4 months after 
birth.90 With the appearance of GCs in mice at 3 weeks of age, they also acquire the ability 
to induce adult-like antibody responses.91 This delayed GC reactivity is due to delayed 
maturation of the essential FDC network, resulting from FDC precursors failing to respond to 
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B cell lymphotoxin-α signalling. This has been shown in mice91, even with potent adjuvants 
that induce adult-like B and T cell interaction.89,91   
 
Table 1.2 Human infant B cell responses. Neonatal and infant B cells respond poorly to 
antigen stimulation and interaction with T cells, resulting in weak primary and secondary 
antibody responses. (Table adapted from Siegrist and Aspinall, 2009) 
 
 
 
1.6.6.2 Neonatal marginal zone B cells 
Neonatal splenic marginal zone B cells are deficient in mice and humans.92 In mice they are 
found after 1-2 weeks of age and in humans they appear after 2 years of life and coincide 
with the ability to mount a response to TI antigens.93 Human neonatal spleens contain fewer 
marginal zone macrophages and these cells differ in their capacity to produce cytokines 
required for B cell activation.94  
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1.6.6.3 Bias towards a memory B cell response 
The most important difference is that the neonatal response favours B cell memory 
induction rather than high affinity antibody production through plasma cell development. 
This preference has been attributed to the combination of many factors (Table 1.2) that are 
highly conserved (at least between mice and humans), and thought to be a protective 
adaptation of the naive neonatal immune system from a prolonged state of heightened 
inflammation in response to overwhelming exposure to antigen which may prove toxic to 
normal development and even survival.67 This has been demonstrated in mice where IL-12 
treatment was used to subvert the Th2 bias and enhance a Th1 response but caused weight 
loss and even death at higher doses.95–98  
 
The preferential differentiation into memory B cells is indicated by the inability to elicit a 
specific primary antibody response with vaccination at birth, while priming a secondary 
response to a boost vaccination. It has been shown that neonatal post-GC plasma cells 
home readily to the bone marrow but fail to establish themselves as long-lived plasmablasts 
due to insufficient differentiation and survival signals from bone marrow stromal cells.99,100 
The impaired ability to generate GC reactions and long lived plasmablasts has implications 
for vaccination with TD antigens and is important in vaccination schemes. 
 
1.6.7 The use of rodent and human cord blood models 
The neonatal immune system has been studied using human umbilical cord blood 
mononuclear cells (CBMCs) as stand-ins for those of the newborn, murine models and other 
mammalian species. The degree of development of soluble and cellular components of 
neonatal immune systems varies widely between mammalian species.74 While the use of 
human CBMCs has been informative and readily available, the modulating effects of the 
corticosteroids and maternal cytokines released during parturition may give false 
impressions of the cell populations circulating in the days after partuition.74  
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While the neonatal period in humans is defined as the first 28 days after birth, the murine 
neonatal period has not been precisely defined. Initial experiments used varying 
immunisation time points ( ≤24 h, ≤48 h and ≤7 days), yielding confusing results.78 Highly 
variable results were obtained from immunisations within the first 3-4 days of life, 
suggestive of the individual variation in appearance of DCs and T cells in peripheral 
lymphoid organs during the first week of life.101,102 Even after neonatal priming at ≤48 h 
after birth, secondary antibody responses were weak. Together these initial experiments 
suggested that murine neonatal immune maturation was delayed compared to humans.78 
However, primary antibody responses elicited in mice aged 1-3 weeks of age compared well 
to those of human neonates and infants, increasing stepwise to an adult-like primary 
antibody response at age ≥4-5 weeks. Thus a neonatal period of 1-2 weeks was established 
with similar responses in BALB/c and C57BL/6 mice.78,103,104 
 
1.7 Experimental Infection Models 
1.7.1 Helminths 
More than 2 billion people worldwide are infected with parasitic helminths and infections 
are particularly prevalent in developing countries of sub-Saharan Africa, parts of Asia and 
South America.105 Infection usually occurs directly through the skin by walking barefoot 
through contaminated faecal matter.106  Infection is chronic and may last 1-5 years for the 
hookworms Nector americanus and about 6 months for Ancylostoma duodenale.107 High 
rates of morbidity rather than mortality are the major health concerns associated with 
helminth infections. Chronic infections often lead to anaemia and protein malnutrition and 
this has been related to poor cognitive development in children108 and can affect maternal 
in utero fetal imprinting.109,110 Strong associations have been made with maternal helminth 
infection and reduced childhood vaccine efficacy in offspring.111 The antihelminthic drug 
albendazole is administered through global strategies to control these infections. However, 
human host inability to develop effective immune memory  and the development of drug 
resistance results in re-infections and confounds these efforts.112 To date no anti-helminth 
vaccine exists but is being actively investigated.113,114 
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1.7.1.1 Nippostrongylus brasiliensis 
N. brasiliensis is a gastro-intestinal (GI) rodent parasite, analogous to the human infectious 
hookworms Ancylostoma duodenale and Necator americanus. N.brasiliensis serves as an 
excellent model to study human hookworms and a highly polarized Th2 immune response in 
mice. It is easy to handle in the laboratory as it does not require an intermediate host for 
the maintenance of its life cycle, is not infectious to humans and not fatal in rodents.115 
 
1.7.1.2 The life cycle of N.brasiliensis 
The life cycle of N.brasiliensis consists of a free-living and a parasitic stage (Fig 2.3). Infection 
occurs by the free-living infectious L3 larvae which penetrate the skin of the rodent. In 
experimental models, the L3 larvae are injected subcutaneously. Once under the skin, L3 
larvae enter the circulation and migrate to the lung over a period of 24-48 hours.116 Here 
they get trapped in capillaries, undergo maturation and moulting to become L4 larvae which 
breach the capillaries and enter the pulmonary alveoli.117 L4 larvae are then coughed up and 
enter the oesophagus through swallowing.118 L4 larvae then migrate through the 
oesophagus and stomach to the small intestine where the final moult to the L5 stage takes 
place and larvae mature into adult worms at day 4-5 post infection. Adult worms establish 
themselves here, lodging in the intestinal epithelium. By day 6 post infection, adult worms 
are now able to mate and produce eggs which leave the host through faeces.117 In BALB/c 
and C57BL/6 mice egg production stops at about day 9 post infection when the worms are 
expelled due to the robust immune response of the host.116,119 
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Figure 1.10 The life cycle of N.brasiliensis. There are six developmental stages in the cycle, 
four larval stages L1-L4 of which L1-L3 are free-living, L4 and the adult L5 are parasitic and 
require a rodent host, and the egg which is produced in the small intestine and leaves the 
host through the faeces. Two main areas in the host undergo pathological changes due to 
infection: the lung and the small intestine. The L3 larva is the infectious stage. (Image 
adapted from Murray Selkirk, Imperial College London) 
 
1.7.1.3 Primary immune response to N.brasiliensis 
The immune response to helminths is a highly polarized Th2 response which includes the 
recruitment of basophils, eosinophils and mast cells,  goblet cell hyperplasia (differentiation 
and proliferation) and mucous secretion, CD4+ T cell dependant generation of IgE and 
isotype switching of B cells to produce IgG1.107,115,117,118 Entry of L3 larvae into the lung upon 
primary infection with N.brasiliensis leads to pulmonary inflammation and induction of this 
Th2 response and causes airway hyper responsiveness.120 This is further characterized by 
the secretion of cytokines IL-4, IL-5, IL-9 and IL-13.15  
 
It is primarily IL-13 that drives the Th2 response to N.brasiliensis and has a wide range of 
Th2 related functions on a variety of cell types. IL-13 is produced by T and B cells, mast cells, 
basophils, DCs and NK cells.121,122 Expulsion of N.brasiliensis from the small intestine in a 
primary infection is dependent on the expression of IL-4Rα, part of the heterodimeric 
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receptors for IL-4 and IL-13 on the cell surface of hematopoietic, muscle, epithelial, 
endothelial cells, fibroblasts and neurons.123 Surprisingly, this expulsion is not due to effects 
of IL-13 signalling on immune cells but, rather, on non-haematopoietic cells such as 
epithelial, goblet and intestinal smooth muscle cells.124–128 It is likely that a combination of 
increased smooth muscle contractility and mucous production creates a hostile 
environment to the adult worms in the small intestine and interferes with their ability to 
feed properly and bind securely to the intestinal wall.118,125,128 
 
1.7.1.4 Secondary immune response to N.brasiliensis 
Humans are unable to develop an effective protective Th2 memory response to helminth 
infections while rodents are. Re-infection studies with nematodes Trichuris muris129, 
Heligmosomoides polygyrus130 and N.brasiliensis131 have demonstrated an enhanced 
memory response that rapidly clears the secondary infection.  
 
Studies with N.brasiliensis show that the lung is the key site of host secondary 
responses.132,133 Although IL-4Rα expression on immune cells is not essential to expulsion of 
the worms in a primary infection, it has been shown to increase the magnitude of the host 
Th2 response through signalling on CD4+ T cells during a primary infection.127 Studies in our 
lab have demonstrated that B cells are essential in the development of effective immune 
memory to N.brasiliensis. B cell production of IL-13, signalling through IL-4Rα and antigen 
presentation all play a role (manuscript in preparation). These data imply an important role 
for adaptive immunity in the memory response to N.brasiliensis. 
 
In this study, we used N.brasiliensis infection as a model for maternal helminth infection to 
assess the effects of this on immunity in offspring. We investigated whether the effects of 
the strong Th2 response to a primary infection on immune cells and cytokine profiles, and 
the development of immune memory in the mother may be transferred to offspring. We 
hypothesized that any altered immune components in offspring are acquired from the 
mother in utero and via breastmilk. 
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1.7.2 Salmonella 
1.7.2.1 The species Salmonella enterica 
Salmonella is a facultative intracellular, non-spore forming Gram-negative bacillus. The 
species of Salmonella are divided based on DNA sequences and include S.enterica and 
S.bongori. These are further divided into subspecies called serovars and defined by their 
surface antigen structure and shared genotype in accordance with the Kauffman-White 
classification scheme.134 S.bongori primarily infects cold blooded animals while S.enterica is 
clinically relevant and causes disease in humans.135 Salmonella enterica serovar Typhus (ST) 
and Salmonella enterica serovar Typhimurium (STm) are almost 98% identical in DNA 
sequence, however 20% of their genes are different and unique to the species.136,137 Where 
ST has an immunodominant antigenic capsular polysaccharide called Vi, used in the 
generation of the Vi vaccine, STm does not. Currently, there is no vaccine against STm. ST 
causes typhoid fever, a serious systemic infection which can be fatal if untreated. STm is a 
non-typhoidal Salmonella (NTS) and causes self-limiting gastroenteritis in developed 
countries.138 However, in sub-Saharan Africa there is a high prevalence of invasive NTS 
disease caused by STm isolates, resulting in severe symptoms in the absence of 
gastroenteritis.139–141 STm disease is discussed in further detail in Chapter 4. 
 
1.7.2.2 Entry and colonisation of the host 
Salmonella disease progression has been characterized based on ST infection. Naturally, 
bacteria are ingested through contaminated food or water and enter the GI tract. The 
severity of disease depends on the ability of the bacteria to disseminate and colonize sites 
remote from where the infection occurred. Bacteria that survive the acidic stomach spread 
rapidly along the GI tract, cross the intestinal epithelium, primarily through membranous 
epithelial cells (M cells) (Fig 2.4).142,143 Salmonella can also enter the penetrate the GI lining 
inside phagocytes and through epithelial cells.144 After penetration, bacteria colonize the 
lamina propria and Payer’s patches where they invade host cells like macrophages and DCs 
and, if host defence responses fail to control the infection, initiate systematic dissemination 
through the lymphatics into deeper tissues. Bacteria translocate to the mesenteric lymph 
nodes (MLN) where they multiply and enter the blood through the thoracic duct. This leads  
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Figure 1.11 Colonisation of the host by Salmonella enterica serovar Typhi resulting in 
persistent infection. Ingested bacteria translocate to the GI tract and cross the mucosal 
barrier of the intestine through M cells and enter the Payer’s patches. Salmonella may then 
target DCs and macrophages which transport them to the MLNs and deeper tissues. This 
then leads to dissemination to the spleen, bone marrow, liver and gall bladder. Bacteria can 
persist in the MLNs, bone marrow and gall bladder for life with periodic reseeding of the 
intestinal lumen.145,147 (Image taken from Monack et al., 2004) 
 
to transient bacteraemia which is cleared by the reticuloendothelial system (RES).145 As 
bacteria continue to replicate within the cells of the RES, secondary bacteraemia results and 
spread to the spleen, bone marrow and non-lymphoid organs such as the liver occurs. Here 
bacteria invade and replicate within macrophages.146 From the liver, bacteria spread to the 
gall bladder which reseeds the lumen of the intestine through bile. Bacteria can persist in 
the MLNs, bone marrow and gall bladder for life with periodic reseeding of the mucosal 
surface.147 
 
1.7.2.3 Immune response to Salmonella enterica serovar Typhimurium 
STm infection in mice can resemble typhoid fever in many respects and  used as an 
experimental model for studying human typhoid and NTS.148 The effective immune response 
to STm in the mouse model is a highly polarized Th1 CD4+ T cell response which effectively  
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clears the infection after 35 days post infection.149–151 The infection kinetic begins with the 
early phase of infection (the first week) where innate cells attempt to kill the colonizing 
bacteria. These cells include neutrophils, macrophages and NK cells (Fig 2.5) which act to 
restrict bacterial multiplication and dissemination before the adaptive response is 
established.142,145,152 STm gastroenteritis infections in humans are completely cleared by 
innate cells. However, in the mouse model of NTS caused by STm, the innate response to 
infection only restricts initial growth but is not able to clear the infection and therefore 
dissemination and bacteraemia occurs. 
 
Figure 1.12 The immune response to Salmonella enterica serovar Typhimurium in mice. 
The early response to infection includes phagocytosis and killing of bacteria by innate cells 
and an extrafollicular low-affinity IgM response, lasting 7 days post infection.145,150 Once the 
adaptive response is established, Th1 CD4+ T cells are recruited and a peak of immune 
activation is reached at 18 days post infection.151 Late in the response to STm, germinal 
centre formation produces high affinity OMPS-specific IgG2a.150 Optimal immunity and 
recall response to vaccination against STm requires both Th1 CD4+ T cells and high affinity 
IgG2a production.153 
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Clearance of infection requires the recruitment of the adaptive response which is discussed 
in more detail in Chapter 4. STm transitions from an extracellular to and intracellular phase 
where the bacteria reside in specialised Salmonella-containing vacuoles (SCVs).144 This 
enables evasion of host antimicrobial defences by preventing phagolysosomal fusion,144 and 
delaying vacuole acidification.154 This new intracellular location of STm requires Th1 cell 
mediated control while, with invasive strains of STm, the extracellular dissemination and 
bacteraemia require humoral control. However, optimal immunity including a memory 
response and vaccine efficacy require both Th1 T cell and antibody mediated immunity.153 
 
1.8 Objectives 
In this study we aim to elucidate the effects of maternal infection with the helminth 
Nippostrongylus brasiliensis on adaptive immunity in offspring. Helminth infections induce a 
highly polarized Th2 response. We hypothesize that a memory-type Th2 response may be 
transferred to offspring in utero and through breastmilk in the form of lymphocytes, 
antibodies and cytokines, imprinting on early offspring immune development and possibly 
extending into later life. Helminth co-infection studies with malaria105 or bacterial 
infections like Salmonella106 have suggested an impaired protective response to both 
pathogens. We further investigated the effects of maternal N.brasiliensis infection on 
offspring control of a highly polarized Th1 inducing pathogen, namely Salmonella enterica 
serovar Typhimurium aroA-/- strain SL3261.       
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2. Materials and Methods 
 
2.1 Animal Work 
2.1.1 Mice used, animal unit and ethics 
This study made use of BALB/c and C57BL/6 mice. Adult females and males used for matings 
were bred by the Animal Unit of the University of Cape Town, and all mice were housed in 
specific pathogen-free conditions in the animal unit facilities. All experimental procedures 
performed on mice were in accordance with protocols 011/008 and 008/009 approved by 
the Faculty of Health Sciences Animal Ethics Committee from the University of Cape Town. 
Mice 
 
2.1.2 Matings and litters 
Female mice aged between 7 and 8 weeks were mated with male mice at one male per cage 
of four females over two weeks after which the male was removed. Females gave birth 21 
days after fertilisation and birth of pups was monitored daily. A maximum of two mothers 
and 8 pups per mother were housed per cage until pups were weaned at 3 weeks of age and 
separated from their mothers according to sex. 
 
2.1.3 Experiment end point 
At specific time points mice were killed by inhalation of halothane. Peripheral blood was 
taken by cardiac puncture and spleens removed by incision under sterile conditions. Blood 
was collected in plasma separation tubes and spun at 8,000rpm for 20min to separate 
plasma from red blood cells. Samples were stored at -20°C. Spleens were weighed whole, 
cut into segments which were weighed separately and used for either flow cytometry, in 
vitro splenocyte restimulation for cytokine assessment by ELISA, immunohistochemistry and 
bacterial culture to determine bacterial burden. 
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2.2 Working with Nippostrongylus brasiliensis 
2.2.1 Cycling of N.brasiliensis 
The life cycle of N.brasiliensis (Nb) was maintained by passage through Wistar rats and 
collection of worm eggs in their faecal pellets (Fig 2.1). Naive 6 week old female rats were 
infected subcutaneously with 5,000 L3 larvae in 1ml of 0.9% NaCl. Rat faecal pellets were 
collected on days 6, 7 and 8 post infection (p.i.) and emulsified in autoclaved water with 
5μg/ml fungizone (Gibco® Life Technologies). Emulsified faeces was spread on moist filter 
paper over gauze (moistened with fungizone water) in petri dishes which were kept in 
humidified boxes at room temperature. After 7 days, the larvae hatched and migrated to 
the edge of the filter paper, where they were harvested at the infective L3 stage for future 
infections of rats (for stock maintenance) and mice (for experimental infection studies). 
 
 
Figure 2.1 Maintenance of the N.brasiliensis life cycle in Wistar rats.  
See Section 2.2.1 for details. (Diagram from W.G. Horsnell) 
 
 
2.2.2 Primary infection with Nb 
Nb L3 larvae were washed off filter paper in 0.9% NaCl solution from pieces of filter paper. 
The larvae were counted under a dissecting microscope and then resuspended at a 
concentration of 2500 L3 larvae/ml in 0.9% NaCl. The infections were carried out in the 
Animal Biosafty Level 2 procedure room in the animal unit (Faculty of Health Sciences, 
University of Cape Town) where mice were injected s.c. with 500 x Nb L3 larvae in 200μl of 
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0.9% NaCl using a 21G needle (Braun, Melsungen, Germany), making sure that the larvae 
were in suspension at the time the syringe was filled. 
 
2.2.3 Clearance of Nb 
While Nb worms are naturally cleared from BALB/c and C57BL/6 mice at approximately 9 
days p.i., to ensure that all worms were expelled mice were treated with 10 mg/ml 
Ivermectin in their drinking water from day 7 to 14 p.i. to clear the pathogen. 
 
2.3 Working with Salmonella enterica serovar Typhimurium 
2.3.1 Growth of S.typhimurium (STm) bacteria 
The attenuated Salmonella enterica serovar Typhimurium AroA-/- SL3261 (STm) strain was 
used throughout this study. STm was stored at -80°C and inoculated into 10ml autoclaved 
3% w/v BactoTM Tryptic Soy Broth (BD BactoTM) supplemented with 0.5% w/v yeast extract in 
dH2O (LB media) the day before infection of mice. Bacteria were grown overnight in LB 
media at 37°C with agitation at 180rpm. 
 
2.3.2 Infection with STm 
The infectious dosage of STm bacteria was harvested by the Miles and Misra method,155 
where, providing that bacteria are harvested at a similar OD reading and diluted accordingly, 
only modest differences in bacterial numbers are found. Bacteria were harvested at late log 
phase with an OD600nm of 1.0. A volume of 1ml of bacterial broth was centrifuged at 
10,000rpm for 5min at 4°C prior to resuspension in 1ml sterile PBS and washing. A volume 
of 1μl of this initial bacterial PBS suspension was taken to equal 5x105 CFU. Bacteria were 
diluted to give the appropriate infectious dose in sterile 1 x PBS. This was designated as neat 
concentration. Pups were infected intra-peritoneally (i.p.) with a dose of 1x105 CFU in 200μl 
sterile 1 x PBS (5x105 CFU/ml) and adult mice were infected i.p. with a dose of 5x105 CFU in 
200μl sterile 1 x PBS (2.5x106 CFU/ml). To check bacterial numbers of the does given to the 
mice, a volume of 100μl diluted bacteria was plated after infection onto LB agar plates 
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(BactoTM Tryptic Soy Broth enriched with yeast extract as described (Section 2.3.1), with 
added 1.2% w/v BactoTM Agar) at 1/10 dilutions from neat down to 1/10,000. Plates were 
incubated overnight at 37°C and CFU were counted the following day to ensure correct 
dosage. 
 
2.3.3 Infection with serum-opsonized STm 
For opsonisation studies the serum to be tested was heated at 56°C for 30min to inactivate 
complement prior to use. In each experiment at least 6 samples of sera per group were 
pooled before coating bacteria. After heat-inactivation, complement-inactivated sera were 
mixed with bacteria which had previously been harvested, washed and the bacterial 
concentration adjusted to 2.5x106 CFU/ml with sterile 1 x PBS. Serum was added at 10% v/v 
of total PBS-bacteria-serum mix and mixed by gentle agitation for 30min at room 
temperature. Adult mice were infected with 5x105 CFU in 200μl sterile 1 x PBS i.p. Bacteria 
were then plated onto LB agar plates and grown overnight at 37°C to check CFU counts of 
the infection dose. 
 
2.4 Vaccination 
2.4.1 Vaccination with heat-killed STm 
Pups were vaccinated with heat-killed STm bacteria which were harvested and washed as 
described (Section 2.3.2). After washing, the 1ml suspension of STm was heat killed by 
incubation at 72˚C for 1 hour after which the bacterial concentration was adjusted to 
2.5x106 CFU/ml in sterile 1 x PBS. Pups were vaccinated with 1x105 heat-killed CFU in 200μl 
sterile PBS. Bacteria were plated and grown overnight at 37°C to confirm that all bacteria 
were non-viable. 
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2.4.2 Vaccination with porins 
Purified porins (OmpC, OmpD and OmpF) from STm (strain ATCC 14028) were generously 
donated by our collaborator Dr. Adam Cunningham at the MRC Centre for Immune 
Regulation, University of Birmingham, UK. Porins were generated by Dr. Cristina Gil-Cruz 
through repeated extraction with sodium dodecyl sulphate (SDS). The detailed protocol is 
described in Appendix B. Porins were diluted to 100μg/ml in sterile 1 x PBS and adult mice 
were immunised i.p. with 20 µg in 200μl. 
 
2.5 Antigen Generation 
2.5.1 Nippostrongylus brasiliensis excretory-secretory antigen (NES) 
NES is N. brasiliensis excretory-secretory antigen and comprises the soluble fraction of 
cellular proteins from Nb L3 larval tissue. L3 larvae were washed from the edge of the filter 
paper, as described (Section 2.2.2), into autoclaved water to which antibiotics Penicillin & 
Streptomycin (Pen/Strep) were added at 50U/ml and 50μg/ml respectively to kill most 
contaminating bacteria. This mixture was left for 1 hour at room temperature to allow the 
larvae to settle at the bottom of the tube. Once settled, the supernatant was aspirated off 
and the larvae were washed twice in Pen/Strep water. The larvae, which are at an unknown 
concentration, were allowed to settle once more. Once settled, the pellet of larvae was 
concentrated into 2 ml of distilled water, transferred to an eppendorf and dipped into liquid 
nitrogen to snap freeze the larvae, thereby disrupting cell walls and membranes and 
releasing the cell contents which include intracellular proteins. Subsequently, disrupted 
larvae were homogenized, centrifuged to pellet out the large insoluble cellular and tissue 
debris and the supernatant, containing the soluble fraction of the larval proteins (including 
NES), was taken for protein quantification. Protein concentration was determined by 
Nanodrop and adjusted to a working concentration of 500μg/ml in volumes of 200μl per 
eppendorf and stored at -80°C for future use. NES was used as coating antigen for antigen 
specific antibody ELISAs at 10μg/ml in 50μl per well or splenocyte restimulating antigen for 
cytokine analysis at 10μg/ml in 200μl per well. 
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2.5.2 STm outer membrane proteins (OMPS) 
OMPS comprise the entire outer membrane of STm, largely consisting of beta-barrel 
proteins (including porins) but likely also containing LPS and lipoprotein. OMPS were 
prepared by our collaborating lab (Dr. Adam Cunningham, University of Birmingham) and 
generously donated for this study. The detailed protocol for their preparation is described in 
Appendix B. OMPS were used as coating antigen for antigen specific antibody ELISAs at a 
concentration of 10μg/ml in 50μl per well. 
 
2.5.3 Heat-killed STm 
HK-STm was prepared as described (Section 2.4.1) for vaccination purposes. The protein 
concentration was determined by Nanodrop, adjusted to a working concentration of 
500μg/ml and stored at -80°C. HK-STm was used for in vitro splenocyte restimulations for 
cytokine analysis at 10μg/ml. 
 
2.5.4 Porins 
Porins were obtained from our collaborators (see Section 2.4.2) and used as coating antigen 
for antigen specific antibody ELISAs at 5μg/ml. 
 
2.6 Cell and Tissue Processing 
2.6.1 Splenocyte resuspension 
Spleen segments to be used for flow cytometry and in vitro splenocyte restimulations were 
kept in complete media comprising Iscovec’s modified Eagle medium (IMDM) (Invitrogen) 
supplemented with 10% heat-inactivated filter-sterilized foetal calf serum (FCS) and 
100U/ml penicillin G and 100μg/ml streptomycin. Single cell resuspension of splenocytes 
was achieved by passing the spleen segment through a 40μm nylon cell strainer (Becton-
Dickson, NJ) using a 2ml syringe plunger. Cells were pelleted (1,200rpm for 5min at 4°C), the 
media discarded and the contaminating red blood cells removed by resuspending the cells 
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in 1ml red cell lysis buffer for 1-2min after which the lysis buffer was neutralized with 2ml 
complete media. Cells were pelleted again and resuspended in complete media, the cells 
now comprising mostly splenic lymphocytes and macrophages. A volume of 10μl was diluted 
and stained in Trypan blue to exclude dead cells and viable cells were counted under a light 
microscope using a haemocytometer slide. Cells were then resuspended at a working 
concentration of 1x107 cells/ml in complete media, now ready for plating for in vitro 
splenocyte restimulation and flow cytometry. 
 
2.6.2 Bacterial culture to determine splenic bacterial burden 
For the assessment of splenic bacterial burden, spleen segments for this purpose were kept 
in IMDM media (Invitrogen) with 10% FCS but without penicillin or streptomycin to ensure 
that STm bacteria were not killed by the antibiotic. Single cell suspensions of splenocytes 
were obtained as described (Section 2.6.1), without resuspension in red cell lysis buffer (the 
presence of red blood cells and cell counting was not important here). The cells were 
resuspended in 1ml antibiotic free media and serially diluted at 1/10, 1/100 and 1/1000. The 
diluted suspensions were plated onto LB agar plates at 100μl per plate and incubated 
overnight at 37°C. Bacterial CFUs were counted and the total CFU per spleen and per gram 
of spleen was determined based on whole spleen mass and dilution of splenocytes. 
 
2.6.3 In vitro restimulation of cells 
Single cell suspensions of splenocytes in complete media (see Section 2.6.1) were plated at 
1x106 cells per well in round-bottomed 96 well plates (Nunc, Maxisorp) and restimulated 
with optimal anti-CD3 (prepared by our lab), NES and/or HK-Tm at 10μg/ml, and/or sub-
optimal anti-CD3 at 1μg/ml mixed with NES at and 10μg/ml in a total volume of 200μl 
complete media. Cells restimulated with optimal anti-CD3 (10μg/ml) were incubated for 36 
hours. Cells restimulated with other antigens were incubated for 72 hours. Cells were then 
pelleted (1,200rpm for 5min at 4°C) and the supernatants frozen at -20°C for cytokine 
analysis by ELISA. 
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2.7 Flow Cytometry 
2.7.1 The basic method 
Flow cytometry (or fluorescent activated cell sorting; FACS) was used to analyse splenic 
lymphocytes for cognate cell surface receptor expression in order to quantify the different 
populations of T and B cells and their maturation and activation statuses. Single cells were 
stained at 1x106 cells/well/sample, in 96-well round-bottom plates (Nunc, Maxisorp). Cells 
were stained with 25μl antibody master mix in MACS buffer (Appendix A) containing 2% rat 
serum and 2% anti-FcγII/III to block non-specific binding, and the required mono-clonal 
antibodies diluted to the correct concentration (Table 2.1) for 30min on ice. Single stain 
controls were prepared with FACS CompBeads (BD, Biosciences) instead of cells. Cells were 
pelleted (1,200rpm for 5min at 4°C) and the antibody mix was washed off with MACS buffer. 
If a secondary antibody stain was required, cells were stained again for 30min at 4°C, 
washed, streptavidin-linked Qdot605 diluted at 1/640 in MACS buffer was added and cells 
were incubated for 20-30min at 4°C. Cells were then washed again and resuspended in 
MACS buffer and read by a 4 laser BECTON DICKINSON FACS FORTESSA machine and the 
data was collected by DIVA© BD software (San Diego, CA). Flow cytometry data was analysed 
by FlowJo© Treestar (Ashland, OR) and graphed with GraphPad Prism software (La Jolla, CA). 
 
2.7.2 Antibodies and gating strategies 
All flow cytometry antibodies (from BD Pharmingen) used in this study and their working 
concentration are listed in Table 2.1. T and B cell populations and sub-populations were 
determined using two main gating strategies (Fig 2.2), with some variations for different 
experiments (outlined in the specific results chapters). Unstained cells and CompBeads were 
used to set parameters on the Facs Fortessa machine. 
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Table 2.1 The monoclonal antibodies used for analysis of T and B cell populations by flow 
cytometry, their fluorophore, clone, isotype control and working concentrations. 
Antibody Fluorophore Clone Isotype Control 
Working 
concentration 
CD3 PE 500A2 IgG2a 1/320 
CD4 PerCP RM4-5 IgG2a 1/1280 
CD8a V500 53-6.7 IgG2a 1/160 
CD44 FITC IM7 IgG2b 1/320 
CD62L APC MEL-14 IgG2a 1/1280 
B220 FITC RA3-6B2 IgG2a 1/370 
CD19 PerCP-Cy 5.5 ID3 IgG2a 1/640 
CD21 APC 7G6 IgG2b 1/640 
CD23 PE B3B4 IgG2a 1/1280 
CD80 V450 16-10A1 IgG2 1/320 
IgG Biotin Polyclonal Ig 1/80 
IgDa FITC 11-26c.2a IgG2a 1/320 
IgMa PE RMM-1 IgG2a 1/20 
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Figure 2.2 Flow cytometry gating strategies for splenic T cells and B cells. Raw data is gated 
for lymphocytes based on size (FSC) and granularity (SSC), then CD3+ cells are separated 
into cytotoxic (CD3+CD8+) and helper (CD3+CD4+) T cells, and the activation status of helper 
T cells is determined as naive (CD44loCD62L
hi), effector (CD44hiCD62Llo), central memory 
(CD44hiCD62Lhi) helper T cells (A). In this case, naive mice were used so central memory T 
cells are a very small proportion of total helper T cells. Lymphocytes are also separates into 
B220+CD19+ B cells, whose maturation status is assessed in terms of newly-formed (NF) 
(CD21-CD23-), follicular (FO) (CD23hiCD21int-lo) and marginal zone (MZ) (CD21hiCD23lo) B 
cells, and activated B cells as CD80+ FO B cells (B). 
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2.8 Enzyme-linked Immunosorbent assay (ELISA) 
2.8.1 Antibody ELISA 
Relative antigen specific serum antibody levels were determined by ELISA. Briefly, flat-
bottomed 96 well plates (Nunc, Maxisorp) were coated with the antigen of interest at the 
required concentration (see Antigen Generation in Section 2.5) diluted in 1 x PBS in a total 
volume of 50μl per well overnight at 4°C. After coating, plates were blocked for 1 hour at 
37°C with 200μl blocking buffer (Appendix A) and then washed 3 times in wash buffer 
(Appendix A). Serum was diluted to a starting concentration of 1/30 or 1/50 in 150μl 
dilution buffer (Appendix A), and serially diluted at 1/3 across six wells. Plates were then 
incubated for 1 hour at 37°C. After incubation, plates were washed and probed with AP-
conjugated goat anti-mouse IgM, IgG, IgG1 and IgG2a secondary antibodies at a dilution of 
1/1000 (Southern Biotech). Plates were then washed and the signal detected using the 
substrate p-Nitrophenylphosphate (PNP) (Sigma-Aldrich) powder at 1mg/ml in substrate 
buffer (Appendix A). Plates were incubated with the substrate at 37°C until the desired 
colour intensity was observed, after which the absorbance was read at λ405 nm using the 
Softmax Pro programme on a VersaMax microplate reader (Molecular Devices Corporation, 
Sunnyvale, CA). Relative antigen specific antibody levels were plotted as dilution graphs or 
as titres in dot plots. All antibody ELISA sandwich antibodies were from BD Pharmingen. 
 
2.8.2 Cytokine ELISA 
Cytokine levels were quantified from supernatants taken from antigen-restimulated 
splenocytes (Section2.6.1). For all solution and antibody details for cytokine ELISAs, refer to 
Appendix A. Briefly, IFNγ and IL-13 levels were quantified by coating flat-bottomed 96 well 
plates (Nunc, Maxisorp) with IFNγ or IL-13 coating antibody, respectively, in 1 x PBS 
overnight at 4°C. After washing and blocking steps were performed as for antibody ELISAs, 
the samples were diluted to a starting concentration of 1/3 in dilution buffer, loaded into 
wells and further diluted 1/3 two times to a final dilution of 1/27. Recombinant protein 
standards were used to generate a standard curve, and diluted serially at 1/3 from 
100ng/ml across 11 wells. Plates were then incubated overnight at 4°C. After washing three 
times, streptavidin-linked horseradish peroxidase (HRP) was added at a dilution of 1/5000 in 
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a volume of 50μl per well and incubated for 1 hour at 37°C. After washing, the plates were 
developed with 50μl TMB Microwell Peroxidase Substrate System (KPL), and once the 
titration of the standard was clearly visible, the reaction was stopped with 25μl 1M H3PO4 
and the signal was read at λ450nm against a reference measurement of λ540nm on a 
VersaMax microplate reader (Molecular Devices Corporation, Sunnyvale, CA). Cytokine 
concentrations from samples were determined from the standard curve. 
 
2.9 Immunohistochemistry 
2.9.1 Spleen sectioning 
Spleen segments that were to be used for immunohistochemistry (IHC) were frozen in liquid 
nitrogen and stored at -80°C until needed. Sectioning was done in the cryostat. Spleen 
segments were mounted onto a chuck on top of a bed of OCT TissueTek compound (Dako) 
which froze the tissue onto the chuck. Sections 7μm in thickness were cut on the cryostat 
and mounted onto four-spot slides (CA Hendley Essex, Ltd). Slides with four sections each 
were left to dry for one hour before fixation in acetone for 20min at 4°C and storage in tin 
foil at -20°C. 
 
2.9.2 Staining of spleen sections 
IHC was carried out as described (Toellner et al., 1996). In brief, slides were labelled with the 
stains to be used, brought up to room temperature and hydrated in Tris buffer (pH 7.6) 
(Appendix A). Sections were subsequently kept in this buffer throughout the staining 
procedure, ensuring that they never dry (or the tissue would crack). Primary antibodies 
were diluted in Tris buffer pH7.6 at the optimum dilution and added to sections which were 
incubated for 1 hour at room temperature and then washed twice for 5 minutes in fresh 
buffer. Secondary antibodies were first adsorbed with 10% normal mouse serum to block 
non-specific binding to mouse sections,  and then added to the slides and incubated for 
45min at room temperature. All antibodies used are listed in Table 2.  Slides were then 
washed as before and streptavidin-complex with alkaline phosphatase (AP) (Dako) was 
added for 30 minutes. Horse-Radish Peroxidase (HRP) and AP reagents were developed 
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sequentially using DAB and napthol AS-MX phosphate with Fast Blue salt (all from Sigma-
Aldrich), respectively (Appendix A). After development slides were washed in Tris buffer pH 
7.6 and then dH2O to remove buffer salts which may cause tissue cracking upon drying. 
Slides were dried at room temperature prior to mounting with coverslips using Immu-mount 
(Thermo Electron Corporation). Photographs were taken using a Leica CTR6000 microscope 
(Leica, Milton Keynes, UK) and QCapture software. Images were processed using Adobe 
Photoshop. 
 
Table 2.2 The antibodies used for dual IHC stains, their chromospheres, isotypes and 
working concentrations. 
Antibody                   
(anti-mouse) 
Chromophore 
used 
Raised in 
Working 
concentration 
Company Clone 
Primary antibodies           
IgD HRP Sheep 1/1000 Abcam Polyclonal 
CD3 AP Rat 1/1000 Abcam KT3 
PNA AP n/a 1/5000 Vector Labs n/a 
IgM AP Rat 1/500 Serotec LO-MM-9 
IgG1 AP Rat 1/500 Abcam LO-MG1-13 
IgG2a AP Rat 1/150 Serotec LOMG2a7 
Antibody Linked to Raised in 
Working 
concentration 
Company Clone 
Secondary antibodies           
Anti-rat Biotin Rabbit 1/500 Abcam Polyclonal 
Anti-Sheep HRP Donkey 1/100 Abcam Polyclonal 
 
 
2.10 Statistics 
The results shown in this study are either from individual mice or as group means ± standard 
error of the mean (SEM). P values and significances were determined using the Mann-
Whitney T-test, non- parametric one-way ANOVA or standard two-way ANOVA with 
Bonferroni post-tests (GraphPad Prism software; La Jolla, CA). Groups were judged to be 
statistically significant when p<0.05 and were indicated with by an asterisk. 
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3. The effect of maternal N.brasiliensis infection on 
immune development in offspring 
 
3.1 Introduction 
Neonates and infants can be highly susceptible to infection due to their poorly developed 
immune memory and an immature B cell repertoire, which can result in relatively weak 
primary antibody responses to infection and vaccination.67 However, the neonatal immune 
system does have a full complement of immune cells at birth. Moreover, the neonatal 
immune system can also mount T and B cell responses comparable to those of an adult (for 
example, with the use of specific adjuvant formulations, supplementation with adult DCs or 
the use of DNA vaccine delivery systems).67,78 Irrespective, neonatal cell populations are 
immature with an impaired ability to launch maximal immune responses. To a large extent 
this immaturity is overcome through antigenic exposure, beginning with exposure to  
maternal immune components in utero and transferred antigen and immune components 
through breastmilk,156 colonization of the gut with commensal microbes,157,158 and exposure 
environmental antigen.159 This experience gradually leads to the development of a pool of 
experienced memory B and T cells and expansion of the infant’s antibody repertoire. 86,160 
Until the infant’s B cell repertoire has developed sufficiently, neonates and infants rely on 
passively acquired maternal antibodies (MatAb) for protection for the first 3-24 months of 
age after which MatAb decline below protective thresholds.161 While MatAb are largely 
protective, they can also inhibit generation of some protective neonatal and infant antibody 
responses (as shown 60 years ago162), preventing the use of several vaccines during infancy, 
such as measles vaccine, oral polio, varicella-zoster, influenza and human rotavirus vaccines 
(reviewed here83). 
 
Since neonatal T and B cells can induce adult-like responses to specific in vitro 
stimulations,67,78 it may be that the fetus can generate its own antibody response following 
in utero antigen stimulation. Evidence that maternal infection or in utero exposure to 
soluble antigen can result in fetal immunologic sensitization has been reported in offspring 
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from mothers infected during pregnancy with mumps163 or toxoplasmosis.164 Moreover, 
antigen specific recall responses to childhood vaccines have been reported in babies whose 
mothers were vaccinated during pregnancy with tetanus toxoid165, streptococcal166 or 
meningococcal vaccines.167 The presence of parasite-specific IgE and IgM in cord blood, 
isotypes that do not normally cross the placenta, suggests that prenatal sensitization to 
chronic parasite infections such as schistosomiasis168 and filiriasis,169,170 can occur. 
Stimulation of antigen specific B cell immunity and helminth antigen specific IgG has also 
been shown in children whose mothers had chronic helminth infections during 
pregnancy.171 Maternal infection with Ascaris lumbricoides has also been associated with 
newborn T cell sensitization to A.lumbricoides. Here, antigen stimulated cord blood from 
newborns born to infected mothers had increased frequencies of CD4+ T cells expressing 
antigen specific IFNγ and IL-4.172 
 
Helminth-specific immunity acquired in utero by infants born to infected mothers has been 
shown to persist into childhood and bias the immune response to BCG vaccination against 
the protection associated IFNγ response.173 In developing countries, women of child-bearing 
age can frequently be infected with one or more helminth parasite.111 Chronic helminthiasis 
can affect immune responses to unrelated antigens within the same host, promoting Th2 
cytokine production and down regulating effector responses by inducing regulatory T cells 
and anti-inflammatory cytokines.174–176 These changes have been associated with 
diminished childhood vaccine efficacy, more rapid progression of and increased 
susceptibility to unrelated infections (reviewed here177).  
 
In the following chapter we present data demonstrating how maternal priming by infection 
with the rodent specific helminth, Nippostrongylus brasiliensis, prior to pregnancy impacts 
on the offspring’s immune system. In particular we examined how this infectious influence 
altered the T and B cell responses of the offspring. 
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3.2 Results 
3.2.1 Maturation of splenic lymphocyte populations with age in naive 
BALB/c pups 
To demonstrate if T and B cell populations in the spleen change with age in neonatal and 
infant BALB/c mice, we analysed the proportions and numbers of these cells in 1, 2, 3 and 6 
week old BALB/c mice born to naive mothers. This data provides an outline as to how these 
cell populations change from the neonatal stage (1 week old) to the young adult (6 week 
old).  
 
As expected both spleen mass and cellularity increased with age. The average spleen mass 
of a 1 week old neonate was 0.042g (±0.0008) increasing to an average of 0.12g (±0.0085) in 
adult 6 week old mice. Splenocyte numbers increased from an average of 2.13x107 
(±3.087x106) splenocytes in 1 week old neonates, peaked at 5.28x107 (±1.36x106) at 3 
weeks, after which they declined to 2.08x107 (±1.92x106) splenocytes in adult 6 week old 
mice. Total lymphocyte proportions remained constant from the neonate to the adult. Total 
lymphocyte numbers changed in accordance with total splenocyte numbers (which contain 
lymphocytes, macrophages and DCs), from an average of 1.36x107 (±1.49x106) in the 
neonate, doubled and peaked at 3.26x107 (±7.81x105) at 3 weeks and dropped to 1.34x107 
(±1.17x106) in the adult. 
 
This pattern conforms to changes in splenic lymphocyte numbers in the peripheral blood of 
other species, namely rabbits, calves, piglets, kittens, and puppies, all of which have low 
numbers at birth which increase rapidly in the first weeks of life and decline in adulthood.74 
However, Spear et al. showed an increase in the splenic nucleated cells of Swiss-L mice from 
approximately 2.5x107 cells per spleen at 1 week to approximately 1x108 cells per spleen at 
5 weeks which was sustained in 10 week old naive mice.160 Swiss-L mice are an outbred 
strain whereas BALB/c mice are inbred, which may account for the differences we see. 
 
Humans have high total lymphocyte numbers at birth, unusual compared to other species, 
but numbers also decrease in adulthood.86 Most studies in the literature assessed circulating  
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Figure 3.1 Maturation of spleen mass, splenocyte  and lymphocyte number and splenic T cell 
populations with age in BALB/c pups. (A) Spleen mass, total splenocytes, proportions and total 
numbers of splenic lymphocytes in 1, 2, 3 and 6 week old naive BALB/c pups born to naive mothers. 
(B) T cell populations were assessed. (C) Percentages of CD4+ helper T cells, naive CD4+ T cells and 
CD8+ cytotoxic T cells, CD44hiCD62Lhi central memory T cells and CD44hiCD62Llo effector helper T cells, 
calculated from total lymphocytes. (D) Total numbers of T cell populations and sub-populations. 
*p<0.05. **p<0.01. **p<0.001. N=3. Experiment was carried out once. 60
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lymphocytes in domestic animals and humans. To the best of our knowledge this data 
represents the first study to examine splenic lymphocyte development with age in BALB/c 
mice. Spleen size and cellularity are one of the indicators of the infection or immunization 
status of mice and humans.  
 
Examination of T and B cell populations revealed age related increases in the proportions of 
these cell populations; however, total numbers of B cells were significantly reduced in the 
adult spleen when compared to the 3 week old spleen. 
3.2.1.1 T cell development 
T cell populations were analyzed as previously described (Fig. 3.1B).The percentage of 
splenic helper T cells (CD3+CD4+) increased with age from 3% in neonatal mice to 20% in 
adult 6 week old mice (Fig.3.1C). Cytotoxic T cells (CD3+CD8+) increased from 1.3% in 
neonatal mice to 7.9% in 6 week old mice. Spear et al. defined a splenic Thy-1+ (θ+) 
population in spleens of Swiss-L mice which was already at 20%±3.6% at birth and increased 
slightly to 27.3% ± 3.9% at 10 weeks, conflicting with our results and evidence in other 
species where peripheral blood lymphocyte numbers are low at birth and then increase.160  
Stobo and Paul showed that murine splenic T cell numbers increase with age.178 
 
Dissection of the activation status of CD3+ CD4+ T cells showed the percentage of naive 
CD4+ T cells increased with age from 2% in the neonate to 17% in the adult. Effector T 
helper cells (CD3+CD4+CD44hiCD62Llo) increased from 1.1% at 1 wk to 3.4% at 6 weeks of 
age, and central memory T cells (CD3+CD4+CD44hiCD62Lhi) also increased from 0.024% at 1 
wk to 0.100% at 6 wks. However, it is interesting to note that activated T cell populations 
comprised a small percentage of the T helper cell repertoire, the majority of cells being 
classed as naïve. This could be expected since these mice are likely to be largely antigen-
inexperienced. 
 
Total T cell numbers of all populations increased with age although the dramatic increase in 
T cell proportions seen between 3 week and 6 week old mice was not apparent in the 
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changes in total numbers, suggesting that T cell numbers stabilized soon after 3 weeks while 
other lymphocyte populations decrease in numbers. 
3.2.1.2 B cell development 
The maturation of splenic B cell populations was assessed in the same 1, 2, 3, and 6 week 
old naive BALB/c mice as previously described: B220+CD19+ B-cells and sub-populations of  
newly formed B cells (NF) (B220+CD19+ CD21-CD23-), marginal zone B cells (MZ) 
(B220+CD19+ CD21hiCD23lo) and  follicular B cells (FO) (B220+CD19+ CD23
hiCD21int-lo) (Fig. 
3.2A). Populations were quantified as percentages of total splenic lymphocytes (Fig. 3.2B 
left) and MZ B cells were also quantified as a percentage of B220+CD19+ B cells (Fig. 3.2B 
right). Proportions of total B220+CD19+ B cells increased from 34% of total splenic 
lymphocytes at 1 wk to 58% at 2 wks and then stabilized at 47% at 3 and 6 wks. Gelfand et 
al. also showed that Ig+ splenic lymphocytes reached adult proportions at between 2 and 4 
weeks.179 Nossal and Pike showed that splenic and peripheral B cells increase rapidly after 
birth, more slowly thereafter and plateau at 5 weeks of age.180  
 
In our study, NF B cells (22%, as a percentage of total splenic lymphocytes) were initially 
greater in proportions than FO B cells (11%) and peaked at 2 wks (36%) with an increase in 
FO B cells (22%), but then decreased at 3wks, along with total B220+CD19+ B cell 
proportions, where NF and FO were equal. NF further decreased in adulthood at 6 wks to 
11% and FO increased to 34% of total splenic lmphocytes, representing the maturation of 
already present NF B cells in the spleen and a decline in their migration from the bone 
marrow to the spleen.181 MZ B cells comprised a small overall proportions at 1 wk and 
increased steadily from 1.4% of total splenic lymphocytes to 5.4% into adulthood, 
corresponding to other studies and coinciding with the ability to mount a response to T-
independent antigens.93 Total splenic B cell numbers of all populations were quantified (Fig. 
3.2C) and MZ B cells were plotted together (left) and apart (right) from other populations 
due to their low numbers. Total splenic B cell numbers followed a similar pattern of 
development; however the peak of total B220+CD19+ B cells, NF and FO B cells was reached 
at 3 wks whereas the peak in proportions of total splenic lymphocytes was reached earlier 
at 2 wks. MZ B cell total cell numbers plateaued at 3 wks. 
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Figure 3.2 Maturation of splenic B cell populations with age in BALB/c pups. (A) Developmental B 
cell populations were assessed in 1, 2, 3 and 6 week old BALB/c pups by flow cytometry. Percentages 
of B cell populations were quantified (B) as a percentage of total lymphocytes (left). Marginal zone B 
cells were quantified as a percentage of total lymphocytes (left) and B220+CD19+ B cells (right). (C) 
Total numbers of B cell populations. Total numbers of marginal zone B cells as compared to total B 
cells , newly formed B cells and follicular B cells (left), and alone (right). *p<0.05. **p<0.01. 
**p<0.001. N=3. Experiment was carried out once.
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Overall, in naive mice splenic T cell populations increase in proportion to total splenic 
lymphocytes until adulthood but their absolute numbers plateau at or soon after 3wks, with 
the exception of central memory CD4+ T cells which decreased again to numbers seen at 2 
wks.  
 
Splenic T cell sub-populations maintain their relative proportions throughout. Splenic B cell 
populations, on the other hand, stabilize in proportion to total lymphocytes at 3 wks, but FO 
B cells become dominant in adulthood where NF B cells were dominant at 1 wk. Absolute 
numbers reach 2.5 times that of adult numbers at 3 wks but then decrease at 6 wks, a 
consistent pattern reported in domestic animals but not in humans, which have 2.2-2.6 
times the count of adult lymphocytes at birth.74,86 
 
In contrast to splenic T cells, non MZ B cells decrease in number in adulthood but remain 
constant in proportion to total splenic lymphocytes. NK cells have also been shown to 
decrease steadily from high numbers at birth in human cord blood to 1/5 of this number in 
adulthood.86 The decline in B cell numbers, and possibly NK cell numbers, within the decline 
in total splenic lymphocytes in adulthood, accounts for the increase in T cell proportions 
without a corresponding increase in T cell numbers and therefore the increase in the T:B cell 
ratio with age in naive BALB/c splenic lymphocytes. This increase in T:B cell ratio into 
adulthood has been reported in Swiss-L mice although neonatal and infant Thy-1+ cell 
proportions were much higher than reported here.160 
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3.2.2 Maternal Nb infection results in an increase in lymphocyte 
populations in offspring 
After defining normal spleen mass and splenic lymphocyte development of neonatal, infant 
and adult naive mice, we assessed how a maternal history of infection with the helminth 
N.brasiliensis (Nb) influenced offspring. Unlike other studies in the literature (Reviewed 
here111), the maternal infection was cleared before mating and pregnancy and there was 
thus no parasite present in the mother during fetal development. However, the presence of 
parasite antigen cannot be excluded. 
 
Mothers were infected at 6 wks of age with 500xL3 Nb larvae or left uninfected (Fig. 3.3A). 
After two weeks an adult BALB/c mouse should clear the infection naturally but both 
infected and uninfected mothers were given Ivermectin in their water bottles to ensure the 
worm was cleared. Mothers were mated after a week of treatment and their offspring was 
killed at 2 wks of age. Pup body mass, spleen mass, total splenocytes, proportion and total 
number of lymphocytes were determined (Fig. 3.3B). Spleen mass and total splenocytes 
were consistent with previously determined spleen mass of naive pups from naive mothers. 
Maternal Nb infection did not have an effect on body mass, spleen mass or total splenocytes 
in 2wk old offspring. However, there was a slight increase in proportions of total splenic 
lymphocytes from an average of 66.6% to 68.9% with maternal Nb infection but this change 
was not statistically significant in total number of lymphocytes. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
A
B
Figure 3.3 Maternal priming with N.brasiliensis infection does not result in changes in mouse body 
mass, spleen mass or total splenocytes numbers in offspring. (A) Experiment mouse plan: 6 week old 
female BALB/c mice were infected with 500xL3 N.brasiliensis (Nb) larvae s.c. or left naive, both groups 
treated with Ivermectin two weeks post infection, mated and their pups were sacrificed two weeks 
after birth. (B) Pup body mass ,spleen mass, total splenocytes, percentage and total number of 
lymphocytes. *p<0.05. N=6-10. Representative of four independent experiments.
0wks 2wks 3wks 6wks 8wks
Maternal Offspring
+/- Nb Ivermectin
Mating &
pregnancy Birth Kill
Naive
Nb
66
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
67 
 
3.2.3 Maternal Nb infection results in an increase in lymphocyte 
populations in offspring 
3.2.3.1 T-cells 
Next we assessed whether maternal Nb infection had more subtle effects in offspring that 
could be seen in changes in lymphocyte populations. Splenic T cell populations in offspring 
were assessed as previously described (Fig. 3.4A). Populations were quantified as 
proportions of total lymphocytes and total numbers per spleen (Fig. 3.4B). Maternal Nb 
infection resulted in a general increase in T cell population proportions and absolute 
numbers: Total helper T cells and cytotoxic T cells, naive CD4+ T cells, effector and central 
memory CD4+ T cells. 
 
Proportions of CD3+CD4+ helper T cells increased from an average of 4.2% of total splenic 
lymphocytes in pups from naive mothers to 6.9% in pups from Nb infected mothers, 
CD3+CD8+ cytotoxic T cells increased from 1.4% to 2.3% with maternal infection. Naive 
helper T cells also increased, from an average of 3.2% to 5.2%. Analysis of T cell activation 
status showed an increase in effector T helper cells (CD3+CD4+CD44hiCD62Llo) from 0.9% to 
1.4%, and an increase in central memory T cells (CD3+CD4+CD44hiCD62Lhi) (p<0.0001 for all 
populations). Total numbers of these T cell populations increased in accordance with their 
increase in proportions. Thus maternal Nb infection resulted in a general increase in naive 
and activated T cell populations in the spleen. 
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Figure 3.4 Maternal Nb priming results in an increase in T cell and proportions and total numbers in 
offspring. (A) CD4+ and CD8+ T cell populations and CD4+ sub-populations were assessed by flow 
cytometry in two week old naive pups from Nb infected of naive mothers. (B) These populations were 
quantified as a percentage of total lymphocytes and as total cell numbers. N=8 pups per 
group.***p<0.001. N=6-10. Representative of four independent experiments.
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3.2.3 Maternal Nb infection results in an increase in lymphocyte 
populations in offspring 
3.2.3.2 B-cells 
Analysis of B cell maturation with maternal Nb infection (Fig. 3.5A) revealed an increase in 
all B cell population proportions and absolute numbers (Fig. 3.5B): Total B220+CD19+ B 
cell proportions increased from an average of 36.4% to 43.1% with a corresponding increase 
in total numbers. FO B cells increased from an average of 13.1% to 15.9%, NF B cells 
increased from an average of 21.6% to 25.1%, and MZ B cells increased from an average of 
0.96% to 1.32%. Activated CD80+ B cells increased from an average of 3.1% to 4.4% with 
maternal infection. 
 
Generally, proportions and numbers of B cell populations were slightly lower than those 
determined previously in 2 week old naive pups from naive mothers and resembled those of 
pups aged between 1 and 2 weeks. While birth time of pups was noted and therefore pups 
were all age matched, differences in litter sizes may affect intrauterine space and 
concentration of transferred immune components per pup, as well as access to breastmilk 
from the mother during suckling. In breeding strategies, litters were kept constant between 
groups of naive and infected mothers, but litters obtained from the animal unit in the 
previous study may not have been consistent with this in numbers per mother and per cage 
and may account for differences in lymphocyte populations between the two experiments. 
 
Since B cell maturation can be examined by a wide range of surface markers, further 
analysis of B cell maturation using IgM and IgD surface immunoglobulins (Fig. 3.6A) 
revealed less pronounced increases in B cell populations. Pre B cells (IgM-IgD-) increased 
from an average of 13.1% to 14.9% with maternal infection and immature B cells (IgDloIgM
hi) 
increased from an average of 6.7% to 7.9% (Fig. 3.6B). Mature recirculating B cells 
(IgDintIgMlo) increased relatively more from 6.6% to 8.1% with maternal infection. 
Transitional B cells (IgDhiIgMhi) did not change with maternal infection. 
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Figure 3.5 Maternal Nb priming results in an increase in B cell proportions and total numbers in 
offspring. (A) B220+CD19+ B cells and B cell developmental sub-populations as well as activated 
CD80+ B cells were assessed by flow cytometry in two week old naive pups from Nb infected of naive 
mothers. (B) These populations were quantified as a percentage of total lymphocytes and as total cell 
numbers. *p<0.05. **p<0.01. **p<0.001. N=6-10. Representative of four independent experiments.
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Figure 3.6 Maternal Nb priming results in an increase in B cell and proportions and total numbers in 
offspring. (A) CD19+ B cells and B cell developmental sub-populations as well as activated were 
assessed by flow cytometry in two week old naive pups from Nb infected of naive mothers. PreB: Pre-
B cells, Imm: Immature, Trans: Transitional, MR: Mature Recirculating. (B) These populations were 
quantified as a percentage of total lymphocytes and as total cell numbers. *p<0.05. **p<0.01. 
**p<0.001. N=6-10. Representative of four independent experiments.
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3.2.4 Offspring from infected mothers have early germinal centre reactions 
Immuno-histochemical analysis of spleens revealed organized splenic lymphocyte 
architecture including T-zones and B cell follicles in 2 week old pups born to naive and Nb 
infected mothers (Fig. 3.7A). IgM+ B cells were present in marginal zones and in extra-
follicular areas in both groups of pups. B1 cells mature with or without antigen to become 
IgM producing cells, and normal serum IgM concentrations are reached in germ-free 
mice.182 Importantly, maternal Nb infection resulted in early formation of germinal centers 
(GCs) in offspring. GCs were absent in offspring from naive mothers. 
 
Neonates and infants have low IgG responses to immunization, increasing with age, and 
most IgG found in serum is of maternal origin.78 We stained spleen sections with IgG1 and 
IgG2a to see whether maternal Nb infection caused priming of B cells to form IgG1 switched 
GCs or extra-follicular IgG responses (Fig. 3.7B). While some blue stain was seen with the 
IgG1 stain, this was due to non-specific staining of non-lymphocyte areas as seen in the wall 
of an arteriole and did not show staining of IgG1+ cells as seen with IgM+ cells. Therefore 
maternal Nb infection did not cause early isotype switching to IgG1 or IgG2a in offspring.  
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Figure 3.7 Maternal Nb priming results in early germinal center formation in offspring. (A) Frozen 
spleen sections from 2 week old pups born to Nb infected or naive mothers were sectioned and 
stained by immunohistochemistry with two dual stains: anti-CD3 (blue) and -IgD (brown) to show T-
zones and B cell follicles respectively, and anti-IgM (blue) and -IgD (brown) to show marginal zones 
and B cell follicles respectively. (B) Sections were stained for IgG1 and IgG2a and assessed for B cell 
isotype switching. No isotype switching was seen. TZ: T-zone, CA: Central arteriole, FO: Follicle, MZ: 
Marginal zone, GC: Germinal center, EF: Extra-follicular, A: Arteriole. N=6. Experiment was carried out 
twice.
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3.2.5 NES-specific antibodies are still present in the mother at 3 weeks 
postpartum 
Next we looked at the antibody repertoire in mothers as this could be representative 
immunoglobulins transferred in utero and via breastfeeding to offspring. Relative levels of 
NES-specific IgG1, IgG2a and IgM were determined in mothers at 3 weeks postpartum (Fig. 
3.8A). As expected, mothers that were infected had high levels of NES-specific IgG1 but 
they also had high levels of NES-specific IgG2a, showing that Nb infection induces both Type 
1 and Type 2 type antibody responses. While infected mothers showed a trend of slightly 
increased NES-specific IgM, this was not statistically significant. Type 1 antigen-specific 
antibodies were assessed as the Salmonella typhimurium (STm) antigen OMPS-specific IgG1, 
IgG2a and IgM (Fig. 3.8B). Both naive and infected mothers had low levels of OMPS-
specific IgG1 and IgG2a, and high levels of OMPS-specific IgM with no differences between 
the groups which may represent naturally occurring IgM antibody. 
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Figure 3.8 Nb specific antibodies are still present in the mother at 3 weeks postpartum whereas 
naturally occurring Th1 type antibodies are unaffected. (A) The relative levels of Nb-specific 
antibodies were determined specific to the Nb antigen NES by ELISA: NES-specific IgM, IgG1 and IgG2a 
in Nb infected and naive mothers 3 weeks postpartum. (B) Relative levels of Th1 type antibodies were 
determined specific to Salmonella typhimurium (STm), using purified outer membrane proteins 
(OMPS) of the bacterium as antigen by ELISA:  STm-specific IgG1, IgG2a and IgM. **p<0.01. 
***p<0.001. N=6. Experiment was carried out once.
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3.2.6 NES-specific antibodies are transferred from infected mothers to 
offspring 
The serum antibody repertoire of offspring was assessed and compared to the MatAb 
repertoire to determine which antibodies may have been transferred. NES-specific IgG1 and 
IgG2a was present in pups born to Nb infected mothers and completely absent in pups born 
to naive mothers, implying that NES-specific IgG1 and IgG2a in offspring were transferred 
from the mother. In rodents, some IgG is transferred across the placenta via the FcRn 
receptor and the balance is absorbed from colostrum and breastmilk from the gut into the 
blood over the first 16-18 days of life until the FcRn receptor is down regulated in the gut.74 
Litter swop experiments from our lab have shown that NES-specific IgG1 is transferred via 
both routes but predominantly by breastmilk (unpublished results).  
 
IgG1 is the most efficiently transferred IgG and IgG2a is the least, while IgG is transferred 
preferentially over IgM.183,184 It is important to note that the ELISA technique does not 
provide a quantitative measure of antibody in the serum, only a relative one. Therefore it is 
not possible to comment on absolute levels of antibodies. NES-specific IgM levels were high 
in both groups, suggesting that this was naturally occurring IgM as seen in extra-follicular 
IgM+ B cells in the spleen IHC and in mothers. B1 B cells are known to produce natural IgM 
antibodies in the absence of antigen stimulation, and these antibodies are polyreactive, 
explaining their cross-reactivity to NES.185 
 
Levels of Type 1 type OMPS-specific IgG1 were low and showed no statistically significant 
differences between the two groups (Fig. 3.9B). OMPS-specific IgG2a levels were low in 
general, but lower in pups from Nb infected mothers, suggesting a possible interference of 
the maternal Nb infection in OMPS-specific IgG2a production in offspring. The presence of 
OMPS-specific IgG2a without STm infection may be due to commensal Salmonella in the gut 
of the young mice.  OMPS-specific IgM levels were high but equal between groups. 
 
To determine how long maternal NES-specific antibodies persisted in the serum of offspring, 
pups from Nb infected and naive mothers were allowed to age. Serum was taken at 8 weeks 
and levels of NES-specific IgG1 and IgG2a were determined (Fig. 3.9C). Now adult mice  
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Figure 3.9 Transfer of maternal NES-specific antibodies in offspring and influence on the presence of 
naturally occurring Th1 antigen-specific antibody. (A) NES-specific IgM, IgG1 and IgG2a in naive 2 
week old pups from Nb infected or naive mothers. (B) STm-specific IgG1, IgG2a and IgM (B). NES-
specific IgG1 and IgG2a were determined in 8 week old adult mice born to Nb infected and naive 
mothers. *p<0.05. ***p<0.001. N=6-8. Representative of at least three independent experiments.
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born to Nb infected mothers still had higher NES-specific IgG1 than mice born to naive 
mothers, although these had higher levels than 2 week old pups born to naive mothers and 
the difference was therefore less pronounced. NES-specific IgG2a levels were the same in 
both groups. In humans and other primates, maternal IgG is transferred solely via the 
placenta and levels  wane after 3-12 months after birth.74 Our study shows that in BALB/c 
mice, maternal Nb-specific IgG1 antibodies are transferred to offspring and persist into 
adulthood.   
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3.3 Discussion 
This study demonstrates that a maternal helminth infection has significant effects on the 
development of splenic T and B cell responses in 2 week old naive pups. We initially 
characterised the splenic lymphocytes populations in mice aged between 1 and 6 weeks. 
Here we found that T and B cell populations showed distinct changes in composition over 
time. Splenic CD4+ and CD8+ T cell populations increased with age in number and 
proportion into adulthood while maintaining their relative proportions. Total splenic 
B220+CD19+ B cells reach adult proportions faster but continue to differentiate into 
follicular and marginal zone B cells between 3 weeks of age and adulthood, while B cell 
numbers rise and fall with total splenic lymphocyte numbers. This is the first study to 
analyze splenic T and B cell populations in neonatal BALB/c mice in such detail since most 
studies have looked at peripheral blood in domestic animals and humans. T 
 
he increase in lymphocyte numbers in early life may be a way in which the neonatal immune 
system attempts to compensate for its naive status.74 Humans are born with high numbers 
of T and B cells which decline 3-6 months after birth.86 The use of newborn mice as models 
for human neonates has been questioned due to the relatively delayed maturation of the 
murine immune system, however the primary antibody response elicited in mice aged 1-3 
weeks is comparable to that of neonatal humans.74,78  
 
This study showed that with maternal Nb infection, 2 week old naive offspring have a 
general increase in splenic B and T lymphocyte populations without increased maturation or 
differentiation of activated T cells, follicular or marginal zone B cells. There was however, a 
more pronounced increase in mature recirculating B cells when compared to Pre B cells and 
immature B cells. While other studies have shown in utero sensitization of the fetus by 
maternal helminth infections,111,168–173,186–188 this is the first study to look at the effects of 
maternal infectious history, i.e. when the parasite has been cleared before pregnancy, on 
immunity in offspring. There is thus little or no helminth antigen leakage across the 
placenta. Effects seen in offspring are therefore due to helminth induced sustained immune 
modulations in the mother being imprinted on the fetus.  
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The effects of colostrum lymphocyte delivered to the neonate should also be considered. 
The leukocyte count in human colostrum is extremely high, ranging from 105 to 107 cells/ml 
of which 40-50% are macrophages, 40-50% neutrophils, and 5-10% lymphocytes.189 Of the 
lymphocytes, about 80% are T cells (CD4+ and CD8+), in which γδ-T cells190 and memory T 
cells predominate.191 Milk macrophages have been shown to contribute to the production 
of cytokines and growth factors in vitro and support antigen mediated proliferation of T 
cells.192 Moreover, transepithelial migration of human milk leukocytes from the gut of the 
offspring and into secondary lymphoid organs through circulation has been shown in rats, 
baboons and other species.156,193 Studies in our lab have shown that antibody-independent 
protection against N.brasiliensis is transferred via breastmilk from mother to offspring in 
BALB/c mice (unpublished results). Thus the effects of breastmilk on systemic immune 
modulation also need to be considered. 
 
We saw the induction of an early germinal center response with maternal Nb infection. GCs 
only appear after 3 weeks of age but we observed GCs in 2 week old mice that had Nb 
infected mothers. These GCs did not produce IgG1 or IgG2a but were surrounded by IgM 
positive B cells in the marginal zone. The neonate is impaired in its production of IgG 
isotypes at birth and responds to a restricted antigen repertoire by production of low 
affinity IgM.194 Nb infection in the mother resulted in increased GC activation. However, this 
was not reflected in the serum which is probably due to the early stages of GC development 
since these GCs were small and present at a low frequency. 
 
NES-specific IgG1 and IgG2a antibodies were present in the serum of offspring from Nb 
infected mothers but completely absent in pups from naive mothers. Since IgG isotypes 
were absent in the spleen, any IgG detected in the serum is most likely of maternal origin, 
passively transferred via the placenta and by breastmilk. However, the possibility of 
transferred remnant antigen cannot be excluded. The presence of NES-specific IgG1 
antibodies in offspring was still detected in adulthood at 8 weeks of age, although levels 
were much reduced. MatAb are known to decline and disappear from the infant’s serum 
antibody repertoire by 12 months in humans. In mice, MatAb have a half life of 7 days but 
remain detectable for 2 months after birth.195 
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The transfer of MatAb is an important effect which may have beneficial and detrimental 
consequences in offspring. Human neonates and infants are protected by maternal antigen-
specific antibodies in serum for the first 3 to 12 months after birth. These MatAb afford 
protection against specific pathogens but also inhibit offspring’s primary antibody responses 
to vaccinations against and infections with those pathogens in a titre dependent manner.196 
It has also been shown that maternal IgG against the allergens ovalbumin and bee venom 
phospholipase A2 (PLA2 ) suppresses the development of IgE against the same antigen in 
offspring, and this effect was maternal IgG titre dependent and independent of maternally 
derived antigen.197 Moreover, anti-PLA2 IgG and IgE recognize non-cross-reactive 
determinants at the minimal dose used in that study,198 suggesting that maternal anti-PLA2 
IgG titres do not suppress the offspring anti-PLA2 IgE response simply by masking 
immunodominant epitopes on the antigen. 
 
Pre-immune B cell repertoires have been shown to be selected in normal naive mice by 
environmental antigens and normal serum immunoglobulins.199 Normal pre-immune 
maternal IgG transferred to offspring stimulates B cell lineage development in offspring, 
favouring the accumulation of immature B cells. Offspring had two- to three-fold higher 
numbers of bone marrow pre-B and B cells and two- to four-fold lower numbers of Ig-
secreting plasma cells in the spleen and thymus, as well as six-fold lower serum IgM 
concentrations.195 Another study in mice showed that maternal vesicular stomatitis virus 
(VSV)- specific antibodies can shape the B cell repertoire of offspring, inhibiting 
accumulation of antigen-specific T2 and MZ B cells and promoting selection into B cell 
follicles, having functional effects long after the MatAb themselves become untedectable.47 
These documented effects of passively transferred MatAb in offspring suggest that the 
observed early GC formation in our study may be related to the presence of maternally 
derived NES-specific IgG which may be priming the neonate’s B cell repertoire development 
and promoting selection into the B cell follicles.  
 
Our study has shown the development of splenic lymphocytes with age from the neonatal 
to adult BALB/c mouse. We then showed that maternal Nb infection results in increased 
lymphocyte proportions and absolute numbers in 2 week old naive offspring, early GC 
formation, transfer of maternal NES-specific IgG, particularly IgG1, which is still present in 
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offspring at adulthood. The next question we asked is whether these factors, especially the 
presence of high titres of maternal helminth specific antibodies and early GC formation, 
influence the control of a Th1 type infection with Salmonella enterica serovar Typhimurium 
in offspring. We also assessed the efficacy of vaccination with heat-killed Salmonella in 
these offspring and whether any observed effects persist into adulthood.   
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4. The effect of maternal N.brasiliensis infection on control 
of S.typhimurium in offspring 
 
4.1 Introduction 
Non-typhoidal Salmonella (NTS) presents as self-limiting gastroenteritis in developed 
countries.138 In sub-Saharan Africa (SSA), NTS infections can cause progressive bacteraemia 
in immunodeficient populations: HIV negative children aged between 6 and 24 months201–
203 and HIV positive adults.204 The period of susceptibility to NTS in children occurs between 
the loss of passively acquired protective MatAb and  before the maturation of the infant’s 
humoral response.67,205 Virulent strains of NTS are “complement resistant”, a trait conferred 
by bacterial surface lipopolysaccharide (LPS) and the outer membrane protein encoded by 
the resistance to complement killing (rck) gene. This complement resistance is overcome by 
protective antibodies which mediate complement bactericidal properties of adult serum, 
and is seen in Malawian children from the age of 24 months.205 
 
 
HIV infection induces permeability of the mucosal surface of the gut, allowing leakage of the 
highly immunogenic LPS of the STm outer membrane.206 In adults LPS elicits a strong 
humoral response, however LPS-specific IgG antibodies are not protective against STm. 
Rather, by crosslinking the distal portion of LPS called the O-antigen, LPS-specific IgG 
impedes the access of complement (in humans) and protective antibodies which bind to 
porins proteins OmpF, C and D on the outer membrane of STm (in humans and mice).207,208 
Therefore, HIV infected individuals have a dysregulated humoral response to STm which 
inhibits protection against bacteraemia.  
 
 
Areas with the highest NTS prevalence typically also have a high prevalence of other 
infections such as malaria201 and helminths.209 Children in SSA experience the highest rate of 
helminth infections.209 It is therefore likely that high prevalence of NTS may be affected by 
helminth co-infections. However, little data exists as to how helminth infections may alter 
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immunity to NTS and whether helminth antibodies or antigen may interfere with protective 
porins-specific antibodies in NTS bacteraemia in children. 
 
Classically, experimental immunology has examined the immune response to single 
pathogens in isolation. However, helminth polyparasitism and co-infections with helminths 
and malaria,209 and helminths and bacteria such as M.tuberculosis210,211(Mtb) are common 
in SSA and may affect the host’s ability to control one or both pathogens, potentially leading 
to prolonged and exacerbated symptoms. Helminth infections are not only highly prevalent 
but also highly immunogenic. Infections elicit a strong Th2 response and asymptomatic 
chronic infection are associated with complex helminth-mediated T-reg and AAM induced 
immune down regulation of the host inflammatory response.11 In a co-infection model, 
helminth influence on host immunity may alter host ability to control other pathogens. 
While helminth-malaria and helminth-Mtb co-infections are common and studies have 
shown that helminth infection is associated with increased susceptibility to malaria,212–215  
the effects of helminth infection on control of malaria parasite and Mtb in the host are 
incongruent. Some studies show impaired control of malaria disease216–218 and TB219 and 
others show improved control of malaria220,221 and TB.211 The variation in effects seems to 
be related to the type of helminth and the time of Mtb infection after the helminth 
infection.219,222  
 
Humans acquire a history of infections over their lifetime, which may influence response to 
new pathogens, affect immune memory development or vaccine efficacy. In depth 
mechanistic studies of the host response to co-infections, the interaction of concurrent 
pathogens, the long-term priming of the immune response by infectious history, and how 
these factors may influence vaccine efficacy are as yet uncommon. Acquisition of protective 
immunity to routine vaccines is diminished in developing countries where helminth 
infections are prevalent.111 Studies have shown that helminth infections impair protective 
immunity acquired from oral polio vaccine,223,224  tetanus toxoid vaccine (TT),225,226  live oral 
cholera vaccine,227,228  BCG,176 malaria vaccine (GMZ2),229 and influenza H1N1 vaccine.230 
Moreover, chronic maternal helminth infection is associated with decreased acquisition of 
protective IgG in children following vaccination with H.influenza type b vaccination.111 
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Objectives 
Preliminary data in our lab, to be discussed in more detail, showed that priming of the 
immune system with Nb infection in BALB/c mice resulted in impaired control of subsequent 
STm infection, and impaired efficacy of the porins STm vaccine.231 Infectious history with 
Nb, a complex Th2-inducing and immune modulating parasite, can therefore exacerbate the 
severity of STm infection, a Th1-inducing bacterium, without the presence of the worm. 
Based on this data and the subtle effects of maternal Nb infection on naive offspring 
lymphocyte populations and transfer of MatAb (described in Chapter 3), we assessed the 
effect of maternal Nb infectious history or “priming” on control of STm in offspring. 
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4.2 Results 
4.2.1 Preliminary results: Primary infection with Nb impairs resolution of 
subsequent STm infection (S. Bobat & W. Horsnell) 
The effect of primary Nb infection on subsequent STm infection was investigated in BALB/c 
mice by Drs. S. Bobat and W. Horsnell in our lab.231 This is not a direct co-infection model as 
the two pathogens are not present in the host at the same time, but examines the effect of 
infectious history with Nb on subsequent STm infection.  
 
Adult BALB/c mice were infected with 500xL3 Nb larvae and at day 16 post infection (6-7 
days post worm expulsion) mice were challenged with 5x105 CFU aroA attenuated strain of 
STm (Fig 4.1A). STm CFU counts were determined in the spleen and liver at day 6 and 25 
post-STm challenge (Fig 4.1B). CFU counts were unaffected by Nb priming at day 6 post 
STm infection. By day 25 post STm, when the adaptive response to STm comes into 
play,151,231,232 CFU counts increased as expected and Nb-primed mice had significantly 
increased bacterial burden in both the spleen and liver. This suggested that primary 
infection with Nb impaired subsequent control of STm.  
 
There was a marginal decrease in CD4+ helper T cells in proportion to total lymphocytes in 
Nb primed mice, and a marginal increase in effector CD4+CD62Llo T cells. This was not 
reflected in absolute numbers of these cells (data not shown). This effect was not related to 
changes in IFNγ levels from anti-CD3 restimulated splenocytes at either day 6 or day 25 (Fig 
4.1C), although NES- and HK-STm-restimulated splenocytes had increased IFNγ levels at day 
6 post STm but not at day 25 (data not shown).  
 
Assessment of antibody specificity (Fig 4.1D) revealed that OMPS-specific IgG levels were 
equivalent at day 6 post STm infection, but were significantly lower in Nb-primed mice at  
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Figure 4.1 Primary infection with Nb impairs resolution of subsequent STm infection (S. Bobat & W. 
Horsnell). (A) BALB/c mice were infected with 500xL3 Nb s.c. alongside naive mice and challenged on 
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IgG, IgG1 and IgG2a titres were determined by ELISA. Antibody graphs represent relative levels. 
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day 25 p.i. However, the protective OMPS-specific IgG2a levels were equivalent (Fig 4.1Di). 
OMPS-specific IgG1 levels did not increase beyond background levels in either group (data 
not shown). As expected, NES-specific IgG, IgG1 and IgG2a levels were high in Nb-primed 
mice only (Fig 4.1Dii). 
 
This data demonstrates that infectious history with Nb disrupts the host’s ability to control 
subsequent STm infection, an effect that is correlated to the time when the adaptive 
response is required to control the later stages of STm infection. No obvious changes in T 
cell populations point to a mechanism, but this does not exclude the role of migration 
and/or communication of immune effectors. The initial adaptive response to STm appears 
unaffected by priming with Nb. Although B cells and antibody are not essential to control of 
primary STm infection, a decrease in STm-specific IgG may have consequences for vaccine 
efficacy and secondary response. 
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4.2.2 Preliminary results: Priming with Nb impairs efficacy of Porin vaccine 
after subsequent immunisation with STm 
(S. Bobat, W. Horsnell & D. Mrdjen) 
 
As described in chapter 2, vaccination with STm porins induces early control of STm 
infection and is dependent on OmpD-specific antibody.208 Since Nb priming could disrupt 
the control of subsequent STm infection in the spleen and liver, and this correlated to a 
decreased OMPS-specific IgG titre, we assessed whether Nb priming could also disrupt the 
protection acquired from vaccination with porins. OMPS contain a mixture of total outer 
membrane proteins of STm and LPS, while porins contain only highly purified porins OmpC, 
OmpD and trace amounts of OmpD, the three major porins of STm.208,231 
 
BALB/c mice were infected with 500xL3 Nb larva for 19 days before vaccination with porins 
for 11 days prior to challenge with 5x106 STm for 5 days (Fig 4.2A). As a control, mice were 
either infected or immunised with Nb only or porins only for 11 days prior to challenge with 
STm. CFU counts in the spleen revealed that unvaccinated Nb-primed mice had a similar 
bacterial load as non-primed unvaccinated mice, an expected outcome since the effects of 
Nb are only seen at day 25 post STm infection (Fig 4.2B). Porins vaccination did indeed 
confer protection against STm infection, as reflected in the almost 104-fold decrease in 
bacterial burden in the vaccinated unprimed group. However, priming with Nb resulted in a 
30-fold greater bacterial burden compared to unprimed mice. Nb infectious history 
therefore disrupted the protection against subsequent STm infection conferred by porins 
vaccination. 
 
Assessment of the porins-specific antibody profile prior to STm infection (Fig 4.2C) 
revealed that priming with Nb had no effect on porins-specific IgM but did result in a 6-fold 
decrease in porins-specific IgG, a 12-fold decrease in porins-specific IgG2a and an 8-fold 
decrease in porins-specific IgG1. This suggested that, since protection conferred by porins 
vaccination is OmpD-specific antibody dependent, disrupted protection by Nb priming may 
be related to disruption of the development of OmpD-specific antibody. However, upon 
assessment of the antibody profile after STm infection, porins-specific IgM and IgG titres  
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Figure 4.2 Priming with Nb impairs efficacy of Porin vaccine after subsequent immunisation with 
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were similar between all groups (Fig 4.1Di), and NES-specific IgM was high in Nb-primed 
mice only (Fig 4.1Dii). Surprisingly, OMPS-specific IgM and IgG responses were broadly 
equivalent between the groups. Unprimed but porin vaccinated mice had a slightly lower 
OMPS-specific IgM response and yet had the greatest level of protection (Fig 4.2Diii). This 
suggests that since there is antibody present but less protection in the Nb-primed porin 
vaccinated mice, the difference is likely to involve a disrupted killing of STm by macrophages 
rather than directly by antibody, possibly due to inappropriate or inefficient opsonisation of 
the bacteria by opsonizing antibody. This remains to be shown by opsonisation experiments 
with various sera in naive or Nb primed mice. 
 
Discussion 
These results show that infectious history with Nb impairs control of subsequent STm 
infection 40 days after clearance of the helminth from the host. This disruption is not 
correlated to any obvious changes in T cell or cytokine responses and is more likely due to 
impaired killing of bacteria by macrophages. Moreover, disruption occurs without continual 
infection with the helminth. Since large amounts of antigen are deposited by the moulting 
and secretion cycle of the helminth,233 it is possible that Nb antigen persists long after 
expulsion of the worms, sustaining the effects on macrophages and/or Th2 polarization. 
While antibody is dispensable in to resolution of primary STm infection and B cell deficient 
mice do not succumb to infection,153 antibody can increase the efficiency of bacterial 
clearance in a secondary infection234 and is required along with T cells for recall immunity to 
oral challenge with mouse-virulent STm C5.235 Furthermore, antibody induced during 
primary infection can help restrict bacteraemia.150 Nb priming also impairs efficacy of the 
porin vaccine, a secondary response to STm infection after vaccination. This is not related to 
changes in OMPS-specific serum IgG, but may be related to the decrease seen in porins-
specific IgG present in circulation before STm challenge and macrophage killing of opsonized 
STm. 
 
These data combined with the high prevalence in SSA of helminth infections in pregnant 
women and NTS infections in children, as well as impaired responses to routine childhood 
vaccinations in these areas, leads to the question of whether the adverse effects of Nb-STm 
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responses seen in the same host could also be seen in a mother-child model. Here the 
effects of a maternal Nb infection may be transferred to the child and affect control of STm 
and vaccine efficacy in the child. In this chapter we investigated this in a mouse model by 
“priming” female mice with an Nb infection prior to pregnancy (as in the previous chapter), 
and challenging offspring with an STm infection. 
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4.2.3 Maternal Nb infection  in BALB/c mice does not impair resolution of 
splenic bacterial burden in young STm infected offspring 
As in the previous chapter, female BALB/c mice were infected with 500xL3 Nb s.c., infection 
was cleared with Ivermectin at 2 weeks p.i. (control groups were also treated) and females 
were mated. In this instance, offspring were infected with 1x105 CFU STm at two weeks of 
age and killed at 7, 18, 27 or 35 days post STm infection (Fig 4.3A). STm CFU counts were 
determined in the spleen as CFU per spleen and per gram of spleen (Fig 4.3 B). The STm 
infection followed the expected progression of bacterial burden seen in adults, starting with 
approximately 106 CFU at day 7 p.i. and clearing the bacteria to approximately 103 CFU at 
day 35 p.i., although adults did clear the infection further to approximately 102 CFU at day 
35 p.i.150 However, there were no differences in CFU counts between pups born to naive or 
Nb infected mothers at any stage in the STm infection.  
 
Spleen mass and total splenocyte numbers (Fig 4.3 C) also followed a similar progression 
as seen in adults, though generally reduced in both parameters since mice were younger. 
Spleen mass reached the peak of splenomegaly at day 18 p.i. after which it declined again 
until day 35 p.i., and total splenocytes were generally high from day 7 until declining at day 
35 p.i. Once again, no differences were seen in spleen mass or total splenocyte numbers 
between pups born to naive or Nb infected mothers. This, however, was also the case for 
spleen mass and total splenocyte numbers in Nb-primed STm infected adult mice in work 
done by Drs S. Bobat and W. Horsnell.231  
 
From this data we can conclude that in BALB/c mice, maternal Nb infection does not alter 
the ability of offspring to control STm infection as seen in splenic bacterial burden. In the 
tissue, primary infection with STm is cleared by a strong Th1 response while bacteraemia 
and secondary infection is controlled by a humoral response against OmpD.149,208 No 
obvious changes in splenic T cell populations were seen in naive pups born to Nb infected 
mothers while a there was a definite and sustained presence of maternal NES-specific IgG1, 
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and a marginal decrease in  naturally occurring OMPS-specific IgG2a. If MatAb do interfere 
with control of STm in offspring, and these antibodies are present in the serum of offspring, 
perhaps maternal Nb infection impacts on bacteraemia in offspring and a better place to 
look would be in the blood of STm infected offspring. 
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Figure 4.3 Maternal Nb infection  in BALB/c mice does not impair resolution of splenic bacterial 
burden in young STM infected offspring. (A) Experiment plan: Female BALB/c mice were infected 
with 500xL3 Nb s.c., infection was cleared with Ivermectin at 2 weeks p.i., females were mated and 
offspring were infected with 1x105CFU STm i.p. at two weeks of age and killed at 7, 18, 27 or 35 days 
post STm infection. (B) STm CFU count per spleen and per gram of spleen. N=6-15. 3-4 pooled 
experiments. No statistical significance.
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4.2.4 Maternal Nb infection alters T cell populations in offspring 
Th1 CD4+ T cells are essential in clearance of STm infection and come into play in the third 
week of infection.149,151 Total splenic CD4+ helper T cells and their activation status were 
analysed throughout the course of the STm infection, as previously described, and a 
representative gating strategy is depicted from day 7 and day 35 p.i. (Fig 4.4A). Subtle 
increases were seen with maternal Nb infection, as seen in naive pups. A progressive 
increase in proportions of CD4+ helper T cells as well as effector and central memory CD4+ T 
cells in proportion to total splenic lymphocytes was seen with age of pups in both groups, as 
expected. 
 
Proportions of total CD4+ helper T cells as a percentage of total splenic lymphocytes were 
increased in pups born to Nb infected mothers at day 7 from 4% to 4.9%, at day 18 from 
4.7% to 7.4%, at day 27 from 14.7% to 18.4% while no statistical significance was seen at 
day 35 (Fig 4.4 Bi left). Differences in total numbers of splenic CD4+ helper T cells were 
only seen at day 27, with an increase from 1.3x107 cells to 1.9x107 cells with maternal Nb 
infection (Fig 4.4 Bi right). Proportions of effector T helper cells 
(CD3+CD4+CD44hiCD62Llo) were increased at days 18, 27 and 35 (Fig 4.4 Bii left) while 
numbers were increased at day 18 only (Fig 4.4 Bii right). Proportions of splenic central 
memory T cells (CD3+CD4+CD44hiCD62Lhi) were increased at days 7 and 18 only (Fig 4.4 
Biii left), and this was also seen in total numbers (Fig 4.4 Biii right). 
 
While not making detailed remarks on the effects of STm infection on T cell populations 
compared to naive mice, total splenic CD4+ T cell proportions were slightly reduced for the 
age of the mice compared to naive mice born to naive mothers (see Fig 3.1 C) while total 
numbers of these cells were generally increased in age-corresponding naive offspring mice 
(day 7 post STm infected mice were 3 weeks of age, and day 27 post STm infected mice 
were 6 weeks of age). However, effector T helper cells were increased in proportions as well 
as numbers compared to naive mice of corresponding age, and central memory T cells were 
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greatly increased in proportion and number. This is in correspondence to the expected 
expansion of STm specific CD4+ T cells and rapid acquisition of Th1 effector function during 
STm infection.236  
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Figure 4.4 Maternal Nb infection increases T cell populations in offspring. (A) Analysis of helper T cell 
populations and activation status, representative examples from offspring born to naive mothers and 
killed at 7 and 35 days post STm infection. (B) Proportions and total numbers of of (i) CD3+CD4+ T-
helper cells, (ii) CD3+CD4+CD44+CD62Llo effector memory T-cells, (iii) CD3+CD4+CD44+CD62Lhi
central memory T-cells. *p<0.05. **p<0.01. ***p<0.001. N=15. Representative of at least three 
experiments.
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4.2.5 Maternal Nb alters B cell populations in young offspring 
B cells are dispensable for clearance of primary infection with attenuated STm.237 Total 
splenic B220+CD19+ B cell populations and their maturation and activation status were 
analysed through the course of the STm infection in pups, as previously described, and 
representative gating strategy is depicted from day 7 and day 35 p.i. (Fig 4.5A). Again, 
subtle changes were seen between pups from naive and infected mothers.  
 
Proportions of total splenic B220+CD19+ B cells were increased slightly from 9.2% to 12.7% 
as a percentage of total splenic lymphocytes with maternal Nb infection at day 7 post STm in 
pups, at day 27 p.i. from 25.6% to 33.4% (Fig 4.5 Bi left). In total numbers, splenic 
B220+CD19+ B cells were increased only at day 7 p.i. (Fig 4.5 Bi right). Activated CD80+ B 
cells were increased at day 7 p.i. from 0.15%  to 0.30%, but decreased from 2.4% to 1.8% at 
day 27 p.i. and from 1.7% to 1.2% at day 35 p.i. (Fig 4.5 Bii left), however only the 
increase at day 7 p.i. was seen in total number of activated CD80+ B cells  (Fig 4.5 Bii 
right). FO B cell proportions were increased at days 7, 18 and 27 p.i. (Fig 4.5 Biii left), 
and numbers at days 7 and 18 (Fig 4.5 Biii right). NF B cell proportions were increased at 
days 7 and 27 (Fig 4.5 Biv left), and numbers at days 7 and 18 (Fig 4.5 Biv right). MZ B 
cells were increased at day 7 p.i. but decreased from 0.64% to 0.38% at day 18 p.i. (Fig 4.5 
Bv left), and this pattern was also seen in total number of MZ B cells (Fig 4.5 v right). 
MatAb have been shown to influence the development of the B cell repertoire of offspring, 
preventing the accumulation of antigen-specific T2 and MZ B cells and promoting their 
selection into B cell follicles. This effect lasted up to adulthood.  
 
Briefly, compared to naive mice from naive mothers in Chapter 3, splenic B cells were lower 
in proportion to total splenic lymphocytes, where naive mice had almost 50% B cells at 3 
and 6 weeks of age, STm infected mice had only 9.2% at 3 weeks and 25.6% at day 27 p.i. 
(see Fig 3.1 B & C). This may be due to the requirement of a T cell response rather than  
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B cell response in clearance of primary STm infection, since effective clearance is completely 
independent of B cells as mice lacking in B cells do not succumb to infection.234,237,238  
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
A
Figure 4.5 Maternal Nb alters B cell populations in young offspring. (A) Analysis of B cell populations 
and activation status, representative examples from offspring born to naive mothers and killed at 7 
and 35 days post STm infection. (B) Proportions and total numbers of (i) B220+CD19+ B cells, (ii) 
activated CD80+ B cells, (iii) CD23hiCD21lo follicular B cells, (iv) CD23loCD21
- newly formed B cells, and 
(v) CD21hiCD23int-lo marginal zone B cells. N=15. Representative of at least three experiments.
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Figure 4.5 Maternal Nb alters B cell populations in young offspring. (A) Analysis of B cell populations 
and activation status, representative examples from offspring born to naive mothers and killed at 7 
and 35 days post STm infection. (B) Proportions and total numbers of (i) B220+CD19+ B cells, (ii) 
activated CD80+ B cells, (iii) CD23hiCD21lo follicular B cells, (iv) CD23loCD21
- newly formed B cells, and 
(v) CD21hiCD23int-lo marginal zone B cells. *p<0.05. **p<0.01. ***p<0.001. N=15. Representative of at 
least three experiments.
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4.2.6 The effect of maternal Nb infection on antibody repertoire and levels 
of IFNγ in young STm infected offspring 
 
We have already shown the pronounced presence of NES-specific IgG1 in 2 week old naive 
pups from Nb infected mothers, assumed to be transferred from the mother in utero and via 
breastmilk, and that the presence of these MatAb is still detectable at 8 weeks of age in 
offspring. We now assessed the effect of STm infection in offspring on the persistence of 
what we assume to be maternally derived NES-specific IgG1. 
 
NES-specific IgG1 was pronounced before STm infection in 2 week old naive pups (day 0 
p.i.), with a 17-fold relative increase compared to pups from naive mothers (Fig 4.6 Ai). 
Antibody levels declined and were 4.2-fold increased in 3 week old STm infected pups at day 
7 p.i. but then increased to 8-fold at day 18 p.i. after which levels were equivalent between 
offspring born to naive and Nb infected mothers. This increase in NES-specific IgG1 between 
days 7 and 18 post STm infection in pups born to Nb infected mothers cannot have been 
due to continued passive transfer from breastmilk as pups are weaned at 3 weeks of age 
(and at day 18p.i. pups are over a month old). Therefore, increased NES-specific IgG1 
between day 7 and 18 post STm may be due to its production by the pup itself. This time 
point corresponds with the peak of immune activation and recruitment of T cells during STm 
infection. MatAb can also prime offspring B cell repertoire, selecting an activated antigen-
specific phenotype.  
 
While OMPS-specific IgG2a was lower in naive pups from Nb infected mothers, relative 
levels were equivalent between groups until day 35 post STm infection where levels were 2-
fold increased in offspring from Nb infected mothers (Fig 4.6 Aii).  
 
STm induces an early extrafollicular switched Type 1 humoral response which is T-
dependent but GCs only form after the first month of infection, corresponding to elevated 
levels of high-affinity IgG2a.150 This is in sharp contrast to the early GC formation of a typical 
Type 2 humoral response where GCs have formed by day 7 p.i. and high affinity antibody  
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Figure 4.6 The effect of maternal Nb infection on antibody repertoire and levels of IFNγ in young 
STm infected offspring. (Ai) Relative change in levels of NES-specific IgG1 and (Aii) OMPS-specific 
IgG2a in  STm infected offspring with Nb infection in the mother throughout the course of STm 
infection. Levels were normalized to  a value of 1 in pups from naive mothers. Absolute levels of IFNγ
secreted by splenocytes restimulated with a (Bi) sub-optimal concentration of anti-CD3 (1μg/ml) and 
NES (10 μg/ml) and (Bii) HK-STm (10μg/ml) from STm infected offspring born to naive and Nb infected 
mothers. *p<0.05, **p<0.01, ***p<0.001. N=6. Antibody analysis  is  from 3 pooled experiments. 
Cytokine analysis was carried out on one experiment.
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are detected after 2 weeks.239 As we saw early formation of GCs in naive pups born to Nb 
infected mothers, it may be possible that the presence of NES-specific IgG1 or maternally 
derived NES antigen/immune complexes enhances the late phase of high affinity antibody 
production by GCs with STm infection. Immunohistochemical analysis of spleens should be 
carried out in these mice to see whether the early GC response is present with STm 
infection, as well as detection of follicle-residing Nb immune complexes which may be 
priming the GC response. 
 
Levels of the Type 1 cytokine IFNγ that acts in clearance of STm infection were quantified. 
Interestingly, levels of IFNγ secreted by splenocytes restimulated with a sub-optimal 
concentration of anti-CD3 (1μg/ml) and NES (10 μg/ml) were decreased at day 7 p.i. from 
77ng/ml to 55.5ng/ml with maternal Nb infection (Fig 4.6Bi), and at day 35 p.i. from 
58.9ng/ml to 22.3ng/ml. Conversely, splenocytes restimulated with HK-STm (10μg/ml) 
secreted higher levels of IFNγ at day 18 p.i. in offspring from Nb infected mothers (Fig 
4.6Bii). Restimulation by NES mixed with sub-optimal anti-CD3 may have been too high and 
may have overridden the NES-specific cytokine response. A better concentration of anti-CD3 
to use may have been 0.1μg/ml. Thus the results may reflect IFNγ production from anti-CD3 
responding splenocytes. T cells are important at day 18 for clearance of bacterial burden 
during STm infection,151 corresponding to the time point when HK-STm-specific IFNγ levels 
were increased in offspring from Nb infected mothers, however no differences were seen in 
bacterial burden at this or any other time point. 
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4.2.7 Maternal Nb infection  in BALB/c mice does not impair resolution of 
STm infection in  adult offspring 
To determine whether maternal Nb infection had any effects on control of STm in offspring 
at a later stage in life, young adult offspring from naive of Nb infected mothers were 
infected with 5x105 STm i.p. at 6 weeks of age instead of 2 weeks and sacrificed at 7, 16, 18 
and 35 days post STm infection (Fig 4.7 A). However, no differences were seen in bacterial 
burden throughout the infection time course (Fig 4.7 B). Spleen mass was increased from 
an approximately 0.7g to approximately 1.1g in offspring from Nb infected mothers (Fig 4.7 
C left). There were no differences between the two groups in total splenocytes (Fig 4.7 C 
right). 
 
As expected, spleens in adults were larger and had more cells than young offspring, but 
bacterial burdens were largely equivalent between adults and pups (see Fig 4.3). 
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Figure 4.7 Maternal Nb infection  in BALB/c mice does not impair resolution of STm infection in  
adult offspring. (A) Experiment plan: Female BALB/c mice were infected with 500xL3 Nb s.c., infection 
was cleared with Ivermectin at 2 weeks p.i., females were mated and offspring were infected with 
5x105CFU STm i.p. at 6weeks of age and killed at 7, 16 or 35 days post STm infection. (B) STm CFU 
count per spleen and per gram of spleen. N=6-15. **p<0.01.Experiment was carried out once.
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4.2.8 The effect of maternal Nb infection on antibody repertoire in adult 
STm infected offspring 
Assessment of the antibody repertoire of adult STm infected offspring revealed that NES-
specific IgG1 was still present at day 7 post STm infection (in now 7 week old mice), as seen 
in naive 8 week old mice (day 0 p.i. in figure) (Fig 4.8 Ai). Moreover, NES-specific IgG1 
levels increased further to 2-fold the levels in offspring from naive mothers at day 18 p.i., as 
seen in young offspring at the same time point during the STm infection (see Fig 4.6 Ai). 
This supports the theory that general immune activation and involvement of T cells at this 
time point in the STm infection kinetic may promote production of NES-specific IgG1 from 
MatAb-primed offspring B cells by facilitating T cell help. 
 
Analysis of OMPS-specific IgG2a levels in adult naive offspring showed a marginal decrease 
in relative levels in offspring from Nb infected mothers, corresponding to a decrease in 
young offspring, but this was not statistically significant in this case (Fig 4.6 Aii). OMPS-
specific IgG2a levels were elevated at day 7 post STm in adult offspring (7 weeks of age) 
from Nb infected mothers, but were equivalent between groups at subsequent time points. 
In young offspring, elevated levels of OMPS-specific IgG2a were seen at day 35 p.i., when 
mice were 7 weeks of age. The significance of this is unclear.  
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Figure 4.8 The effect of maternal Nb infection on antibody repertoire in adult STm infected 
offspring. Relative change in levels of (Ai) NES-specific IgG1 and (Aii) OMPS-specific IgG2a in  STm 
infected adult offspring with Nb infection in the mother throughout the course of STm infection. 
Levels were normalized to  a value of 1 in pups from naive mothers. *p<0.05, **p<0.01, ***p<0.001. 
N=6. Analysis was carried out on one experiment.
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4.2.9 Breastfeeding by Nb infected mothers has no impact on control of 
splenic STm bacterial burden in foster pups 
To determine the effect of maternal Nb infectious history on the influence of breastfeeding 
and the transfer of immune components through breastmilk, we carried out litter swop 
experiments. Once again, female BALB/c mice were infected with 500xL3 Nb s.c., infection 
was cleared with Ivermectin at 2 weeks p.i. (controls were also treated), and females were 
mated. Offspring born to these mothers was then replaced with 5-day old naive foster pups 
from separate naive mothers and these pups were infected with 1x105CFU STm at 2 weeks 
of age and killed at 18 days post STm infection (Fig 4.9 A). There were no differences in 
splenic bacterial burden in foster pups at day 18 post STm infection (Fig 4.9 B), and no 
effect was seen on spleen mass and total splenocyte numbers (Fig 4.9 C). Therefore, 
breastmilk from Nb infected mothers does not influence offspring to such an extent that it 
modifies control of another infection. However, we now wanted to dissect the effect of 
maternal breastmilk on immune components in offspring. 
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Figure 4.9 Breastfeeding by Nb infected mothers has no impact on control of splenic STm bacterial 
burden in foster pups. (A) Experiment plan: Female BALB/c mice were infected with 500xL3 Nb s.c., 
infection was cleared with Ivermectin at 2 weeks p.i., females were mated and their offspring was 
replaced with 5-day old naive foster pups from naive mothers and these pups were infected with 
1x105CFU STm i.p. at 2 weeks of age and killed at 18 days post STm infection. (B) STm CFU count per 
spleen and per gram of spleen. (C) Spleen mass and total splenocytes. Dots represent individual mice. 
Experiment was carried out once.
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4.2.10 Cytokine response in STm infected foster pups breastfed by Nb 
infected mothers 
The effect of breastmilk from Nb infected mothers on Type 1 and Type 2 cytokine levels in 
foster pups was assessed by ELISA. Levels of IFNγ were quantified from splenocytes 
restimulated with optimal anti-CD3 (10μg/ml), HK-STm (10μg/ml) and NES (10μg/ml) alone 
(Fig 4.10 A). Pups fostered by Nb infected mothers showed a decline in IFNγ from an 
average of 915ng/ml to an average of 555ng/ml from anti-CD3 restimulated splenocytes, 
but this was not statistically significant. HK-STm restimulated splenocytes produced 
approximately 3 times more IFNγ in pups fostered by Nb infected mothers and NES 
restimulated splenocytes produced approximately 15 times more IFNγ in pups fostered by 
Nb infected mothers. Similar cytokine profiles were seen in experiments performed by Drs 
S. Bobat and W. Horsnell: Nb primed STm infected adult mice also showed elevated IFNγ 
levels from NES- and HK-STm-restimulated splenocytes and equivalent levels from anti-CD3 
restimulated splenocytes, however this was at day 6 post STm infection while our results are 
form day 18 post STm.231 
 
Levels of IL-13 were quantified from splenocytes restimulated with optimal anti-CD3 
(10μg/ml), HK-STm (10μg/ml) and NES (10μg/ml) alone (Fig 4.10 B). IL-13 is required for 
clearance of Nb through IL-4Rα signalling240,241 but is not involved in clearance of STm. IL-13 
levels were increased i  foster pups breastfed by Nb infected mothers when splenocytes 
were restimulated with anti-CD3, where pups fostered by naive mothers had an average of 
2.2ng/ml, pups fostered by Nb infected mothers had an average of 6.8ng/ml. There was no 
IL-13 production by splenocytes restimulated by NES from pups fostered by naive mothers; 
however pups fostered by Nb infected mothers had an average of 1ng/ml IL-13.  HK-STm 
restimulation also showed an increase in IL-13 production but this was not statistically 
significant.  
 
IFNγ is the predominant cytokine transferred in breastmilk and levels of other cytokines are 
normally low in human breastmilk.242 However, human milk mononuclear cells have been 
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shown to produce other cytokines by in vitro stimulation.192 Antibody and antigen is also 
transferred through breastmilk.243 However, we find that splenocytes from offspring appear 
primed to produce higher levels of cytokines not only specific to NES but also to HK-STm and 
by general activation of T cells with anti-CD3. Therefore, this cytokine production may occur 
by a generalized activation of offspring splenocytes by breastmilk transferred immune 
components like NES-specific IgG1 and cytokines, possibly in combination with transferred 
NES/immune complexes, which activate the cells of offspring. 
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Figure 4.10 Cytokine response in STm infected foster pups breastfed by Nb infected mothers. (A) 
Levels of IFNγ were quantified from splenocytes restimulated with optimal anti-CD3 (10μg/ml), HK-
STm (10μg/ml) and NES (10μg/ml) alone. (B) Levels of IL-13 were quantified from splenocytes 
restimulated with optimal anti-CD3 (10μg/ml), HK-STm (10μg/ml) and NES (10μg/ml) alone. *p<0.05. 
**p<0.01. Dots represent individual mice. Analysis was carried out on one experiment.
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4.2.11 Transfer of NES-specific maternal antibodies from Nb infected foster 
mothers and the influence on OMPS-specific antibody in STm infected 
foster pups 
Assessment of the antibody repertoire of STm infected foster pups revealed the presence of 
NES-specific IgG1 in those breastfed by Nb infected mothers, which was absent in pups 
fostered by naive mothers (Fig 4.11 A). This shows that MatAb is transferred via 
breastmilk. In Chapter 3 we showed that NES-specific IgG1 is found in the serum and not in 
the spleen in naive 2 week old pups born to Nb infected mothers, and therefore must be 
passively transferred via breastmilk or in utero. In this experiment the pups were born to 
naive mothers but breastfed by Nb infected mothers, are now 4.5 weeks of age, and were 
weaned at 3 weeks. MatAb is still detectable in naive mice until 2 months of age.195 The 
presence of NES-specific IgG1 is likely the remnant of antibody transferred through 
breastmilk. The source may also be the humoral response of the pup itself responding to 
activation by MatAb. Trance amounts of transferred NES immune complexes may also 
contribute. The early GC formation seen in 2 week old naive pups supports the hypothesis 
that offspring B cell repertoires are influenced and selected for an activated phenotype, and 
that this may prime the pup’s later humoral response. 
 
OMPS-specific antibody levels were determined (Fig 4.11 B). OMPS-specific IgM, IgG and 
IgG1 were found to be decreased in pups fostered by Nb infected mothers; however levels 
of OMPS-specific IgG2a, the Type 1 antibody important in later control of STm infection, 
were equivalent between groups of foster pups. In previous experiments equivalent levels 
of OMPS-specific IgG2a were also seen between groups of pups but other OMPS-specific Ig 
isotypes were not assessed. Here we see that they are decreased when the mother has 
been infected with Nb and this may again be due to priming by MatAb and trace NES 
immune complexes. 
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Figure 4.11 Transfer of NES-specific maternal antibodies from Nb infected foster mothers and the 
influence on OMPS-specific antibody in STM infected foster pups. (A) NES-specific IgM, IgG, IgG1 and 
IgG2a levels and (B) OMPS-specific IgM, IgG, IgG1 and IgG2a were determined by ELISA in foster pups 
breastfed by naive and Nb infected mothers. ***p<0.001. N=6. Analysis was carried out on one 
experiment.
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4.2.12 Maternal Nb priming does not affect control of splenic bacterial 
burden in offspring infected with STm after vaccination with HK-STm 
Although no effects of maternal Nb priming were seen on control of splenic bacterial burden 
in a primary STm infection in offspring, we tested whether maternal Nb priming had an 
effect on secondary response to STm in offspring. Once again, Nb infected mothers were 
mated after clearance of the worms. At 2 weeks of age offspring were vaccinated with 20μg 
HK-STm, infected with 1x10
5
CFU STm i.p. 2 weeks post vaccination and killed at 5 days later 
(Fig 4.12 A). Splenic bacterial burdens were quantified per spleen and per gram of spleen 
(Fig 4.12 B). Although unvaccinated controls were not included, and will be for future 
publications, splenic CFU counts were greatly reduced in both groups compared to previous 
unvaccinated groups (see day 7 p.i., Fig 4.3 B) where counts were over 106 CFU per spleen at 
day 7 post STm. However, no differences in CFU counts were seen between pups born to 
naive and Nb infected mothers. Also, there was no change in spleen mass or total 
splenocytes in STm infected and HK-STm vaccinated pups (Fig 4.12 Ci), or uninfected but 
vaccinated pups born to naive or Nb infected mothers (Fig 4.12 Cii).  
 
Heat killed Salmonella is an approved vaccine against Salmonella serovar Typhi (ST) and not 
STm.244,245 The porins vaccine has been shown to protect against STm208 but this was not 
available at the time of the experiment. The difference between HK-STm and porins is that 
during heat inactivation, the antibody inducing porins are denatured in HK-STm and lose 
their ability to bind to antigen specific BCRs and induce the protective antibody response. 
Thus if maternal antibodies play a role here, an effect due to maternal Nb priming may be 
seen in offspring vaccinated with the porins vaccine. 
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Figure 4.12 Maternal Nb infection does not affect control of splenic bacterial burden in offspring 
infected with STm  after vaccination with HK-STm. (A) Experiment plan: Female BALB/c mice were 
infected with 500xL3 Nb s.c., infection was cleared with Ivermectin at 2 weeks p.i., females were 
mated and offspring was vaccinated with 20μg HK-STm at 2 weeks of age. Two weeks post 
vaccination, offspring was infected with 1x105CFU STm i.p. and killed at 5 days later. (B) STm CFU 
count per spleen and per gram of spleen. (Ci) Spleen mass and total splenocytes from vaccinated and 
STm infected pups and (Cii) vaccinated but uninfected pups. Dots represent individual mice. STm 
infected experiment was carried out twice. Uninfected vaccination experiment was carried out once.
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4.2.13 Maternal Nb infection  in C57BL/6 mice impairs resolution of splenic 
bacterial burden in young STm infected offspring 
The different genetic background of laboratory mice accounts for varied Th1/Th2 balance in 
response to infection, a critical aspect in the control of many diseases.246 BALB/c mice are a 
Th2 dominant strain, i.e. they control Th2-inducing pathogens like Nb more efficiently than 
Th1-inducing pathogens like STm, while C57CBL/6 mice are a Th1 dominant strain, i.e. they 
control Th1-inducing pathogens like STm more efficiently than Th2-inducing pathogens like 
Nb.247 No effects of Nb priming in BALB/c mothers were seen on control of splenic bacterial 
burden in offspring. We now tested whether there were any effects in C57BL/6 mice. 
 
The same experimental procedure was followed. Female C57BL/6 mice were infected with 
500xL3 Nb s.c., infection was cleared with Ivermectin at 2 weeks p.i. (controls were also 
treated), females were mated and offspring were infected with 1x105CFU STm i.p. at two 
weeks of age and killed at 7 and 27 days post STm infection (Fig 4.13 A). This time, Nb 
priming in the mother impaired control of splenic bacterial burden in offspring. This was 
seen in a marginal increase in CFU per spleen at day 7 post STm, from 7.5x106 CFU in pups 
from naive mothers to 1.1x107 CFU in pups from Nb infected mothers, and more 
dramatically at day 27 post STm, from 4.3x105 CFU per spleen to 3.1x106 CFU with maternal 
Nb priming, a time point when the adaptive response to STm becomes important (Fig 4.13 
Bi). While the expected increase in splenomegaly between day 7 and 27 was seen in both 
groups of pups, there were no differences in spleen mass between the groups (Fig 4.13 
Bii). Unfortunately, due to time constraints, further analysis of cell populations, antibody 
repertoire, cytokine responses in these pups was not possible. 
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Figure 4.13 Maternal Nb infection  in C57BL/6 mice impairs resolution of splenic bacterial burden in 
young STM infected offspring. (A) Experiment plan: Female C57BL/6 mice were infected with 500xL3 
Nb s.c., infection was cleared with Ivermectin at 2 weeks p.i., females were mated and offspring were 
infected with 1x105CFU STm i.p. at two weeks of age and killed at 7 and 27 days post STm infection. 
(Bi) STm CFU count per spleen and per gram of spleen and (Bii) spleen mass. N=8-15. 
*p<0.05.***p<0.001. Experiment was carried out once.
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4.3 Discussion 
In BALB/c mice, maternal priming with Nb did not affect control of splenic bacterial burden 
in young or adult offspring after STm infection at any time point throughout the infection. 
However, in young offspring, maternal Nb infection was linked to subtle changes in splenic T 
and B cell populations. Subtle changes were also seen in naive pups born Nb infected 
mothers and this may reflect the influence of maternal inflammation in the form of 
transferred MatAb, cytokines and/or NES immune complexes, on the young developing 
immune system. 
 
Most notably, the presence of NES-specific IgG1 was still seen at day 7 and 18 post STm 
infection. This is most likely due to continued transfer of MatAb via breastmilk until 3 weeks 
of age. MatAb is still detected in naive mice up to 2 months of age.195 As mentioned in 
Chapter 3, maternal IgG can prime offspring B cells and influence B cell repertoire 
development.200 This may explain the increase that we see here in activated CD80+ B cells at 
day 7 post STm and FO B cells at days 7, 18 and 27 post STm, in pups whose mothers were 
infected with Nb. Furthermore, NES-specific IgG1 levels increase between day 7 and 18 post 
STm and this may reflect 1) the peak of immune activation and CD4+ T cell recruitment 
during the STm infection, promoting any GC reactions which may have been primed by the 
maternal Nb infection, and/or 2) B cell priming by MatAb to produce more NES-specific 
IgG1. In adult offspring, NES-specific IgG1 was present in naive adult mice born to Nb 
infected mothers, was lower at day 7 post STm and levels also increased at day 18.   
 
The effects of maternally derived NES antigen should also be taken into account, however 
antigen transferred with antigen-specific antibody would be quickly removed by 
phagocytes. FDCs can capture and retain antigen, unprocessed in the form of immune 
complexes, in B cell follicles for up to a year.60 NES may be retained in this was by FDCs and 
may stimulate NES-specific IgG1 production through GC reactions in the pups. Whether NES 
is actually transferred from mothers that have been treated with Ivermectin should be 
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assessed, and whether amounts of NES transferred are sufficient to provide this level of 
antigenic stimulation in offspring may be questionable. 
 
The elevated levels of OMPS-specific IgG2a, the antibody that helps control bacteraemia in 
STm infection, seen at day 35 p.i. corresponds to the time point when high affinity IgG2a 
produced by GC reactions is present during the STm infection time course.150 The fact that 
levels of this antibody are elevated may be due to a generally more activated immune 
system due to priming with MatAb. 
 
NES-specific IgG1 was present in foster pups breastfed by Nb infected mothers and 
associated with lower levels of OMPS-specific IgM and IgG1 but not IgG2a. Breastmilk 
associated increase in IFNγ levels from NES and HK-STm restimulated splenocytes and IL-13 
from anti-CD3 and NES restimulated splenocytes in young offspring fostered by Nb infected 
mothers suggests that mothers may transfer cytokines and/or NES antigen through 
breastmilk which cross the epithelial layer in the gut of their pups and enter the spleen 
through the circulation. What exactly is transferred through breastmilk and in utero and 
accounts for the changes in serum antibody, splenic cytokine levels and cell populations 
remains to be elucidated. 
 
Interestingly, when the experiment model was repeated in C57BL/6 mice, an impairment in 
the control of splenic bacterial burden was seen in STm infected offspring whose mothers 
had been Nb infected. This change was marginal at day 7 p.i. and pronounced at day 27 p.i. 
(by one log difference). Different commonly used mouse strains have varied levels of 
susceptibility to intracellular pathogens like STm, a trait associated with a macrophage 
divalent cation transporter called Slc11a1 (also known as Nramp1).248 A single mutation in 
Slc11a1 determines resistance (Gly169) or susceptibility (Asp169).249 Paradoxically to this 
study, both BALB/c and C57BL/6 mouse strains are innately susceptible to infection with 
virulent strains of STm compared to, for example, A/J or CBA mice, but do clear live 
attenuated STm which we used in our study.250,251 Therefore Slc11a1 mutations may not be 
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responsible for the differences we see here. However, genetic background in mice is also 
important for the Th1/Th2 balance in response to infection: BALB/c mice are Th2 dominant 
and C57BL/6 mice are Th1 dominant. In addition to T cell responses, the Th1/Th2 function of 
innate cells also differs between these two mouse strains. Macrophages from BALB/c mice 
show impaired bactericidal activity and reduced IFNγ production relative to those from 
C57BL/6 mice.247,252 Therefore, when studying the effects of two pathogens that induce 
opposing Th responses, like Nb and STm, it is important to consider the possible effects of 
the genetic background of the mouse strain used. 
 
Since C57BL/6 mice are better than BALB/c mice at clearing intracellular pathogens, the 
effect on control of STm may be due to the different Th2 response from the maternal Nb 
infection between the two mouse strains. Although it is an attractive idea to propose that 
the Th1 bias of C57BL/6 mice may result in a more severe Nb infection in the mothers, 
resulting in more pronounced effects on their offspring and accounting for the impaired 
control of STm that we see here, BALB/c and C57BL/6 mice also clear Nb infections at the 
same rate.15 Further experiments need to be conducted to determine why we see this effect 
in C57BL/6 mice and not in BALB/c mice. Based on analysis done in the BALB/c model it is 
possible to speculate that in C57BL/6 mice maternal NES-specific antibodies and cytokines 
as well as NES immune complexes are transferred, and that offspring have early germinal 
centre formation which may be Th2 biased. These factors may impair a Th1 response to 
STm, including a down regulation of CAMs and killing of bacteria and an upregulation of 
AAMs, a characteristic of helminth infections. 
 
While antibody is dispensable for the control of primary STm infection, it does help to 
control bacteraemia and increases efficiency of bacterial clearance during secondary 
infection.150,234 MatAb are known to interfere with the development of the infant’s own 
humoral response.82 Although these interfering antibodies are specific to the same antigen, 
it is plausible to suggest that maternal NES-specific IgG1 interferes with control of STm 
infection by the presence of a dysregulated humoral response which inhibits the protective 
humoral response, similar to that seen in HIV positive adults also infected with STm.207 This 
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study did not look at STm CFU counts in the blood and therefore we cannot say whether this 
is true in mice. Maternal PLA2-specific IgG was shown to inhibit production of PLA2-specific 
IgE in offspring.197 Similarly, maternal NES-specific IgG1 may inhibit production of OMPS-
specific IgG2a in offspring. 
 
The effect of maternal Nb infection on the humoral response of offspring to STm is an 
important point to consider in human infants infected with virulent strains of STm which 
require protective OMPS-specific antibodies to control bacteraemia. Weak neonatal and 
infant humoral responses may be further disadvantaged if their mothers were infected with 
one or even multiple helminths and passed on helminth specific IgG1 to their children. 
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5. The effect of maternal N.brasiliensis infection on serum 
protection against S.typhimurium 
 
5.1 Introduction 
As mentioned, antibody is not essential in the clearance of a primary STm infection where 
CD4+ T cells are the main effectors of infection clearance.149 Indeed, the effector antibody, 
STm-specific IgG2a, is only elicited late in the infection timeline (after day 20 p.i.) when the 
splenic bacterial burden is already low.150 However, antibody is very important in increasing 
the efficiency of bacterial clearance during a secondary response.238 Antibody induced 
during a primary infection can help restrict bacteremia,150 and B1b cell derived antibody is 
required for the protection seen with the porins vaccine.208 Moreover, simultaneous 
adoptive transfer of both opsonizing immune serum with CD4+ T cells drives protection of 
BALB/c mice against the virulent strain S.typhimurium C5.235 Thus both T cells and antibody 
are involved in optimal resistance to STm challenge.153,208,235,237  
 
Antibodies can protect in a cell-independent manner through complement-dependent 
bactericidal activity. Antibodies can also protect in a cell-dependent manner through the 
uptake and killing by phagocytes of antibody opsonized bacteria (antibody dependent cell 
mediated cytotoxicity, ADCC). In humans, cell-independent complement mediated killing of 
STm is activated by IgM and IgG and occurs by formation of the membrane attack 
complex.253 However, virulent NTS strains are commonly complement-resistant due to the 
large amount of LPS-specific antibodies that are generated which crosslink outer membrane 
O-antigens on LPS molecules and impede access of complement to the outer membrane (as 
mentioned in Chapter 4). This suggests that ADCC by macrophages is likely more important 
in vivo.254 Mouse serum is not effective at cell-independent complement mediated activity 
and membrane attack complex formation against NTS. Therefore mice rely solely on 
phagocytosis by ADCC for protection in the blood.255  
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Objectives 
We have shown that maternal Nb infection in mice results in the presence of what we 
assume to be in utero and breastmilk maternally transferred NES-specific IgG1 antibody in 
pups which persists into adulthood. We have also shown that pups born to Nb infected 
mothers have early formation of splenic GCs which may mean that offspring B cell 
repertoire is influenced by MatAb. The maternal infection does not, however, result in an 
impaired ability to control STm in neonatal or adult pups in BALB/c mice. We now wanted to 
test in a vaccination model system whether the altered antibody repertoire and early 
germinal centre formation of naive pups born to Nb infected mothers affects serum-
opsonized bacterial clearance (by ADCC) of STm in adult naive BALB/c mice.  
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
127 
 
5.2 Results 
5.2.1 Opsonization experiment plan 
To assess the effects of maternal Nb infection solely on the protective ability of serum from 
naive pups against STm infection, we conducted an opsonization experiment using serum 
from pup and mother donors and infected naive adult BALB/c mice with serum-opsonized 
STm. 
 
As before, female BALB/c mice were infected with 500xL3 Nb s.c., infection was cleared with 
Ivermectin at 2 weeks p.i. (controls were also treated) and females were mated (Fig 5.1A). 
Their offspring were killed at 3wks and 6wks of age and blood was harvested by cardiac 
puncture. Mothers were tail bled at 3 weeks post partum to determine the circulating 
antibodies which may be transferred to offspring via breastmilk. These pups and mothers 
are now called the serum donors. Sera from the serum donors were used to opsonize 2x106 
CFU STm which was used to infect new naive adult BALB/c mice, killed 5 days p.i. to 
determine splenic bacterial burden (Fig 5.1B). 
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Figure 5.1 Opsonisation experiment plan. (A) 6 week old female BALB/c mice were infected 
with 500xL3 N.brasiliensis (Nb) larvae s.c. or left naive, both groups treated with Ivermectin 
two weeks post infection, mated and their pups were sacrificed and blood taken three and six 
weeks after birth. Mothers were also tail bled at three weeks postpartum. (B) Serum from 
three and six week old pups born to naive and infected mothers, as well as from the mothers 
themselves at 3 weeks postpartum, was used to opsonized 2x106 CFU STm after heat 
inactivation of complement,. Naive BALB/c mice were then infected with serum-opsonized STm 
and sacrificed 5 days p.i. for splenic bacterial counts.
A
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5.2.2 Protective ability against STm of naive infant pup serum from 3 week 
old pups born to naive or infected mothers 
Spleen mass and splenic bacterial burden was determined from mice infected with STm 
opsonized with serum from naive infant pups 3wks of age, born to naive or infected 
mothers, as well as serum from the mothers themselves at 3 weeks postpartum. This was 
compared to control serum which was taken from adult mice infected with STm and killed at 
day 35 p.i. when humoral immunity to STm has developed (Fig 5.2). 
 
An increased spleen mass was seen from an average of 0.44g to an average of 0.53g when 
STm was opsonized with serum from pups born to infected mothers, but this was not 
statistically significant (Fig 5.2A). Spleen mass was largely equivalent in the maternal group 
(an average or 0.44g in naive mothers and an average of 0.42g in infected mothers), where 
donor serum was from maternal tail bleeds at 3 weeks postpartum, and this was also similar 
to the pup group. In the control group where serum was expected to be highly protective, 
the spleen mass was reduced to an average of 0.21g, suggesting a lesser degree of 
lymphocyte expansion and a higher degree of infection control by ADCC. 
 
Splenic bacterial burden showed that, as expected, the control serum from Salmonella 
infected mice was protective against STm infection with a CFU count of 2.25x104 CFU per 
spleen (Fig 5.2B). Humoral protection against STm is achieved by increasing the efficiency 
of macrophage phagocytosis and clearance of antibody coated bacteria.256 There was no 
statistically significant difference in bacterial clearance between opsonization with serum 
from infant pups born to naive or infected mothers. No difference in bacterial burden was 
found in recipients of bacteria opsonized with maternal serum derived from naïve or Nb 
infected mothers. 
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Figure 5.2 Protective ability against STm of naive infant pup serum from 3wk old pups born 
to naive or infected mothers. (A) Spleen mass of naive adult BALB/c mice infected with STm 
opsonized with serum from naive 3wk old pups born to naive or infected mothers, or from the 
mothers themselves at 3 weeks postpartum, or from adult mice infected with STm and 
sacrificed 35 days p.i. (B) STm CFU count per spleen and per gram of spleen from mice in (A). 
N=8. Experiment was carried out once. ***p<0.001.
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When comparing bacterial burden in 3wk old infant pup serum to maternal serum, infant 
pup serum had an impaired ability to clear bacteria. Where pup serum was used, the 
average CFU count per spleen for the whole pup group was 2.35x106, whereas the average 
CFU count per spleen for the whole maternal group was 5x105. This was also seen in CFU 
per gram of spleen. This finding may be a reflection of the Th2 biased immune system and 
the poorly developed humoral immune system of the neonate. Where adult mothers will 
have a normal ability to mount a Th1 response and may have more natural polyreactive and 
antigen-specific IgM from B1a B cells and MZ B cells,58 and antigen specific IgA from B1a B 
cell priming by commensal bacetria,64,65 neonates still posses the in utero derived Th2 
biased response and have yet to fully develop adult humoral immunity as well as their 
normal commensal bacteria.257 
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5.2.3 Protective ability against STm of naive adult pup serum from 3 week 
old pups born to naive or infected mothers 
Spleen mass and splenic bacterial burden was determined from mice infected with STm 
opsonized with serum from naive adult pups 6wks of age, born to naive or infected mothers, 
as well as serum from the mothers themselves at 3 weeks postpartum (Fig 5.3). 
 
The NES- and STm-specific antibody repertoires of the donor adult pup and maternal sera 
were determined (Fig 5.3A), showing the presence of NES-specific IgG1 levels in adult pups 
born to Nb infected mothers and its absence in adult pups born to naive mothers. STm-
specific IgG1 was low and equivalent between the groups.  NES-specific IgG1 was also 
present in the maternal serum when mothers were infected with Nb, but absent in naive 
mothers. STm-specific IgG1 and IgG2a levels were low and equivalent between the groups. 
 
When these donor sera were used to opsonize STm and infect new naive adult BALB/c mice, 
no differences were seen in spleen mass (Fig 5.3B). Interestingly, splenic bacterial burdens 
revealed that when serum from naive adult pups born to naive mothers was used, the CFU 
count per spleen was 1.0x106 where CFU count per spleen was 2.2x106 when serum from 
naive adult pups born to infected mothers was used (Fig 5.3 C). This impaired protective 
ability is also seen in CFU counts per gram of spleen.  
 
Maternal serum from infected mothers cleared the infection better than serum from naive 
mothers. While this result was not seen in the previous opsonization experiment where 
maternal serum was also used from 3 weeks postpartum, this difference was not great 
(2.9x10 CFU per spleen with naive maternal serum compared to 2.3x10 CFU per spleen with 
infected maternal serum) and may be accounted for by freeze-thawing of the serum. 
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Figure 5.3 Protective ability against STm of adult pup serum from 6wk old pups born to naive 
and infected mothers. (A) Relative antibody levels from donor serum used to opsonize 2x106
CFU STm: NES-specific IgG1 and STm-specific IgG1 from naive adult 6wk old pups born to naive 
or infected mothers, NES-specific IgG1, STm-specific IgG1 and STm-specific IgG2a from naive or 
infected mothers themselves tail bled at 3 weeks postpartum. (B) Spleen mass from adult 
BALB/c mice infected with serum-opsonized STm from pups and mothers in (A). (C) STm CFU 
counts per spleen and per gram of spleen from mice in (B). N=8. Experiment was carried out 
once. *p<0.05. **p<0.01. ***p<0.001.
Serum donors:
A
B
C
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When maternal serum was used to opsonize the STm, splenic CFU counts were largely 
similar to the adult pup serum donor group (an average of 2.6x106 CFU per spleen with 
maternal serum, and 1.6x106 CFU per spleen with adult pup serum). Thus adult pups do not 
have the impaired clearance ability compared to adult maternal serum seen when infant 
pup serum was used in section 5.2.2. As Expected, this indicates that the 6wk old pups have 
overcome the neonatal Th2 bias and have developed their humoral immune system and 
natural antibody repertoire to match that of adult maternal serum, and demonstrates the 
high susceptibility of young infants to bacterial infection. 
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5.3 Discussion 
Our opsonization model looks solely at the effects of maternal Nb infection on the ability of 
the serum antibody of naive offspring to opsonize STm and enhance clearance by 
phagocytes of a naive adult mouse. Table 5.1 summarizes the serum groups used to 
opsonize STm and infect naive adult mice. Serum was heat inactivated so changes in pups' 
complement system are not relevant here (though complement-mediated bactericidal 
activity of mouse serum is ineffective in any case). 
 
Table 5.1 Summary of serum used to opsonize STm for infection of naive adult mice. 
Serum donor 
Infection 
status 
Age 
Infection status 
of mother 
   Pups Naive 3 wks or 6 wks Naive 
Opsonize 
STm 
 Infect naive 
adult mouse 
Pups Naive 3 wks or 6 wks Infected 
 
Mothers of pups Naive 3 wks postpartum Naive 
 Mothers of pups Infected 3 wks postpartum Naive 
  
In summary of this experiment, our findings were: 1) The serum of 3 week old naive pups 
born to Nb infected mothers had the same opsonizing ability of STm as the serum of pups 
born to naive mothers; 2) The serum of 6 week old naive pups born to Nb infected mothers 
had impaired opsonizing ability of STm compared to the serum from pups born to naive 
mothers; 3) Maternal serum was much better at opsonizing STm than 3 week old pup 
serum; and 4) This difference between maternal and pup serum was negated when 6 week 
old pup serum was used.  
 
MatAb are known to interfere with neonatal and infant humoral responses to infection and 
vaccination by epitope masking of immunodominant vaccine epitopes and also by the 
uptake of MatAb:antigen immune complexes by neonatal APCs.78 However, in this case the 
antibodies are antigen-specific and the mother and offspring have the same or overlapping 
antigen experience. OmpD-specific IgG2a protects against STm while NES-specific IgG1 is 
elicited in Nb infections and (we assume) transferred from mother to offspring. The 
presence of MatAb in offspring wanes with age and is stronger in younger pups which have 
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just been weaned (i.e. 3wk old pups) than in adult pups (6wk old pups). In this experiment, 
we see an impaired opsonizing ability of pup serum due to maternal Nb infection only once 
the pup has reached adulthood and not when high titres of MatAb are present. Therefore 
the impaired opsonizing ability of pup serum is not dependent on the titre of MatAb. Our 
results suggest that the maternal Nb infection has a long term effect on the offspring 
antibody repertoire and only affects control of STm later, once the offspring’s adaptive 
response is fully mature. This may be mediated by the influence of MatAb on offspring B cell 
repertoire development and subsequent production of normal antibody against commensal 
bacteria, including STm, or polyreactive antibody by B1a and MZ B cells, which may then 
affect opsonization of STm. 
 
Our opsonization data also revealed that neonatal serum is less able to opsonize STm than 
adult maternal serum. This may be explained by the Th2 bias of neonatal immunity, 
imprinted onto the fetus in utero by the maternal immune system to avoid rejection of the 
fetal allograft by an inflammatory Th1 response.258 With a Th2 biased antibody response 
(producing IgG1 and IgE rather than IgG2a), as well as a generally weak humoral response 
and underdeveloped colonization by commensal bacteria, the neonatal immune system may 
not be able to produce natural IgM and IgG antibodies that adults can and this may be 
responsible for the impaired opsonization ability of STm by neonatal serum.  
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6. Concluding Remarks 
6.1 Summary of results 
In SSA pregnant women are often infected with one or more helminth during pregnancy. 
This maternal infection is strongly correlated with impaired vaccine efficacy of standard 
vaccinations like Hib in their children.111 In SSA a high prevalence of helminth infections 
overlaps with a high prevalence of other multi drug resistant infections such as NTS,259 
particularly in young children. Children between the ages of 6 and 24 months are highly 
susceptible to NTS which results in progressive bacteraemia and even death.201,202,260 
Maternal helminth infection appears to alter the immune development of their offspring 
with deleterious effects on protective responses to other pathogens. This effect may further 
exacerbate the high susceptibility of young children to infections such as NTS in areas where 
helminth infections are common. Few studies have addressed how a maternal helminth 
infection may alter offspring immunity. 
 
Our study showed that in mice, maternal infection with the helminth N.brasiliensis impacts 
on immune development of offspring. There was a pronounced presence of NES-specific 
IgG1 in offspring born to and/or fostered by Nb infected mothers, suggesting that MatAb is 
transferred in utero and through breastmilk. NES-specific IgG1 is still detectable in 8 week 
old offspring. Offspring have early GC reactions in the spleen and altered splenic T and B cell 
populations. Other studies have shown that MatAb can alter the development of the B cell 
repertoire of offspring,195,200 promoting an activated phenotype during infection and the 
selection of B cells into follicles and that this effect is long-lasting.200 Maternally derived IgG 
has been shown to have effects on isotype switching in offspring, suppressing the 
production of IgE in response to allergen.197 Maternal NES-specific IgG1 may therefore 
influence the development of offspring B cells, promoting activation of GCs and the 
production of Type 2 antibodies like IgG1.  
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We hypothesized that a maternal infection with a highly Th2 polarizing pathogen like Nb 
may impair control of a highly polarizing Th1 pathogen like Salmonella enterica serovar 
Typhimurium in offspring. We found that maternal Nb infection in BALB/c mice does not 
affect control of STm in offspring or HK-STm vaccine efficacy. It does, however, still results in 
a pronounced presence of NES-specific IgG1 as well as subtle changes in splenic T and B cell 
population, breastmilk associated increased cytokine production and the presence of NES-
specific IL-13 (the critical Type 2 cytokine involved in clearance of Nb). 
 
BALB/c mice are Th2 biased where C57BL/6 mice are Th1 biased. When we changed our 
mouse model to C57BL/6, we found that maternal Nb infection in C57BL/6 mice impairs 
control of STm in young offspring. Since C57BL/6 and BALB/c mice are both susceptible to 
STm infection and both clear Nb infection at the same rate, further experiments are needed 
to determine why we see this impaired control in C57BL/6 mice but not in BALB/c mice.  
 
Control of STm infections differs between mice and humans. In the murine model the strain 
used is attenuated (AroA-/- SL3261) and is not lethal whereas human infections are with 
invasive virulent strains of STm. Virulent strains are also used in experimental mouse models 
but these are fatal. Where the CD4+ T cell response is critical in the control of STm in mice149 
and a humoral response is dispensable in a primary infection,238 antibody and CD4+ T cells 
are required to control bacteraemia and tissue infection in humans.153 These are important 
aspects to consider when assessing effects of maternal helminth infection on STm in 
offspring as changes in B cell and antibody repertoires may play a larger role in human STm 
infection. 
 
Our opsonization experiments showed that serum from naive adult offspring born to Nb 
infected mothers had reduced natural ability to opsonize STm than serum from offspring 
born to naive mothers. We did not see any effect when we used the serum of young 
offspring when higher titres of MatAb are present. This suggests that functional effects of 
maternal Nb infection on offspring antibody repertoire in terms of STm clearance by 
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antibody dependent cell mediated cytotoxicity may be long-term, having an impaired effect 
on the development of a natural humoral response. 
 
6.2 Future work 
This project has shown that a maternal Nb infection has significant effects on the immune 
development and response in offspring which may extend to an impaired response to other 
pathogens.  Further mechanistic experiments should be carried out in order to identify how 
maternal immune components prime and potentially bias the immune response of their 
offspring. 
 
Immunohistochemistry and B cell selection in the spleen 
We hypothesize that MatAb affect the development of B cells in offspring, promoting 
selection into B cell follicles and early GC formation. This can be further investigated by 
immunohistochemical (IHC) analysis of spleen sections to see the progression and expansion 
of GC development with age in offspring born to Nb infected mothers and to characterize 
the antibody specificity of these GCs. IHC should also be used to determine whether NES 
immune complexes are transferred from the Nb infected mother and retained on FDCs in 
the follicles of offspring as these, along with MatAb, may activate offspring B cells. 
 
The significance of maternal antibodies on offspring B cell repertoire 
To determine the significance of maternal antibodies, breeding strategies with homozygous 
B cell deficient μMT/μMT or heterozygous μMT /+ females mated with μMT/μMT or μMT/+ 
males, respectively, could be carried out. We could thus compare normal or B cell deficient 
pups born from Ig- deprived (Ig-) or phenotypically normal mothers (Ig+). This has already 
been carried out in previous studies with naive mothers.195 In our study we could assess the 
impact of the maternal Nb infection on the influence of maternal antibody on offspring B 
cell repertoire and antibody production. We could further analyze the functional effects of 
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the serum of STm infected offspring born to Nb infected B cell deficient or normal mothers 
by carrying out opsonization experiments with STm. 
 
Mechanistic experiments in C57BL/6 mice 
Experiments to determine how the maternal Nb infection modulates offspring’s immune 
system in C57BL/6 mice should be carried out. This includes determining the antibody, 
cytokine and lymphocyte repertoire in C57BL/6 offspring. The macrophage population in 
STm infected pups should also be characterized to determine whether there is a bias to 
helminth-induced AAM population rather than the protective CAM population which may 
then affect ADCC activity through altered macrophage-antibody activity. The efficacy of the 
porins vaccine in offspring born to Nb infected mothers should also be tested in these mice.  
 
Gene expression in the intrauterine environment 
Maternal-offspring experiments are difficult to control and highly variable results are 
common among individual mouse and human neonates. In mice, factors like lactation, litter 
size and maternal stress vary and can influence experiments. This has also been reported in 
other studies.78 A better, more controlled way to understand the intrauterine effects of a 
maternal helminth infection on the fetus would be to perform RT-PCR on genes of interest 
on placental and embryonic tissues. With the advantage of pooled litter samples and 
controls like housekeeping genes, these results may provide important direction to how the 
fetal immune development is being affected by maternal imprinting. 
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7. Appendices 
 
7.1 Appendix A – STm protein preparations 
 
7.1.1 Isolation of purified porins for immunization 
Purified porins from STm (strain ATCC 14028) were extracted by Dr. Cristina- Gil Cruz 
through repeated extraction with SDS. In brief, STm were incubated in minimal salts 
medium (MAM) containing 0.1% yeast extract, 0.5% glucose and 0.1% MgSO4 at 37°C with 
agitation (200rpm) until late log phase (OD600nm of 1.0). Cells were then diluted 1:10 in 1.5L 
MAM and further incubated until late log phase. Cells were harvested at 6000 x g at 4°C for 
15min and washed in wash buffer. Cells were then resuspended in wash buffer and 
disrupted using a French Press at 20,000 psi. Unbroken cells were removed by 
centrifugation (6,000 x g at 4°C for 20min) and the supernatant was centrifuged again at 
(30,000 x g at 4°C for 40min). The resulting pellet now contained the envelope fraction and 
was resuspended in 100ml solubilisation buffer and incubated for 2hrs at 37°C with 
agitation (120 rpm). The soluble inner membrane fraction was then separated from the 
insoluble outer membrane (OM) by centrifugation (30,000 x g at 4°C for 45min). This 
extraction step was performed twice. Pelleted cells (OM envelope) were resuspended in 
Nikaido buffer and incubated at 37°C for 1 hour with agitation (120rpm) before 
centrifugation at 30,000 x g at 20°C for 1hr. The resulting supernatant isolated after this 
third extraction contained the OM fraction. 
 
Final purification was achieved by FPLC gel filtration on a Sephacryl S-200 column with 
Nikaido’s purification buffer. Fractions with an OD at λ280 nm of >0.2 were pooled and 
extensively dialysed against PBS containing 0.1% (w/v) SDS. Purity was assessed by SDS-
PAGE and protein concentration using the BCA assay. The Limulus Amoebocyte Lysate (LAL) 
assay was used to detect bacterial Endotoxin from purified proteins as per manufacturer’s 
guidelines (Sigma Aldrich, Poole, UK). The LAL assay showed LPS contamination to be 
0.06EU/480µg protein. Protein identity was confirmed by trypsin digest and Quadrupole 
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Time of Flight (QTOF) mass spectrometry at the School of Biosciences Functional Proteomics 
Unit (University of Birmingham). Protein was stored at -80°C and transported from the UK 
on dry ice. 
 
7.1.2 Isolation of STm outer membrane proteins for ELISA antigen coating 
This process is similar to that described for porins purification. A volume of 5ml LB broth 
was inoculated with STm bacteria culture (strain AroA-/- SL3261) and grown overnight at 
37°C with agitation (180rpm). The following day 100ml of sterile LB broth was inoculated 
with a 1/1000 dilution of the overnight bacterial culture and grown up to late log phase 
(OD600nm of 1.0) at 37°C with agitation (150rpm). Cells were harvested by centrifugation 
(10,000 x g at 4°C for 10min) using the 250ml high speed centrifuge pots. The supernatant 
was discarded and the pellet resuspended in 20ml of 10mM Tris buffer pH7.4 containing 
2mM PMSF. Cells were then disrupted using a French Press at 20,000 psi three times. This 
suspension was then centrifuged (6,000 x g at 4°C for 10mins) to remove unbroken cells. 
The supernatant was poured off into another 50ml centrifuge tube and the pellet discarded. 
This supernatant was the centrifuges once more (30,000 x g at 4°C for 90mins) to separate 
the envelope and cytoplasmic fractions. The supernatant was discarded and the pelleted 
envelopes were resuspended in 10ml of 10mM Tris Buffer pH 7.4 with 2% (v/v) TritonX-100 
and incubated in a water bath at 25°C for 15mins. This allows solubilisation of the inner 
membrane. The envelopes, now dissolved in the TritonX-100, were harvested by 
centrifugation (30,000 x g at 4°C for 90 min). The supernatant was discarded and the pellet 
washed three times and resuspended in 1ml of 10mM Tris Buffer pH 7.4. The pelleted 
material now contains predominantly outer membrane. This was then aliquoted into 250μl 
quantities and store at -20°C or -80°C. Samples were run on a gel at neat, 1/2 and 1/5 
concentrations at 150V to check purity. The concentration of outer membrane proteins 
(Omps) was calculated by performing a BCA protein assay. 
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7.2 Appendix B – Buffers 
 
Flow cytometry: 
MACS buffer 
2mM EDTA  
0.5% BSA 
Dissolve the above reagents in a final volume of 1000ml of 1X PBS and store at 4°C. 
 
ELISA: 
ELISA blocking buffer 
20g fat-free milk powder 
0.2g NaN3 
Dissolve reagents in a final volume of 1000ml 1X PBS and store at 4°C. 
 
ELISA wash buffer (20X) 
20g KCL  
20g KH2HPO4.2H2O  
800g NaCl  
50ml Tween-20  
100ml 10% NaN3  
Make up to 5L with ddH2O and store at room temperature. Dilute in 1:20 in ddH2O. 
 
ELISA dilution buffer  
10g BSA  
0.2g NaN3 
Dissolve the above reagents in a final volume of 1000ml of 1X PBS and store at 4°C. 
 
ELISA substrate buffer (for horseradish peroxidase conjugates)  
TMB Peroxidase Substrate Solution A (Roche Diagnostics GmbH)  
Peroxidase Substrate Solution B (Roche Diagnostics GmbH, Mannheim, Germany)  
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Just before use, mix equal volumes of TMB Peroxidase Substrate (Solution A) with 
Peroxidase Substrate Solution B. 
 
Table 7.1 Cytokine ELISA antibodies and solutions (discussed in Section 2.8.2) 
Cytokine 
Coating 
antibody 
Detection 
antibody 
Protein standard Sensitivity 
IFNγ 
Rat anti-mouse 
IFNγ 
Biotinylated rat 
anti-mouse IFNγ 
Recombinant IFNγ 46pg/ml 
Concentration 1/500 1/1000 100ng/ml   
Company BD-Pharmingen BD Biosciences BD Biosciences   
Clone R4-6A2 XMG1.2 n/a   
IL-13 
Rat anti-mouse 
IL-13 
Biotinylated rat 
anti-mouse IL-13 
Recombinant IL-
13 
46pg/ml 
Concentration 1/500 1/500 100ng/ml   
Company R&D Systems R&D Systems BD Biosciences   
Clone 38213.11 Polyclonal n/a   
 
 
Immunohistochemistry: 
Tris buffer pH7.6  
1L of 200mM Tris base  
1.5L of 154mM physiological NaCl  
1.0L of 0.1 N HCl 
Check pH. 
 
Tris buffer pH9.2  
As above but at pH 9.2.  
Initially pH 200 ml to give pH9.2 using HCl (dropwise with 1M or greater) and make up to 
desired volume with NaCl. 
 
  
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
145 
 
Horseradish peroxidase substrate  
Dissolve a single 3-3’-diaminobenzidine tetrahydrochloride (DAB) tablet (Sigma Aldrich) in 
15ml Tris buffer pH7.6. Filter to 10ml and add 1 drop of hydrogen peroxide (Sigma Aldrich). 
A single drop of HRP substrate was added to each section until the desired level of positivity 
was reached, whereupon slides were washed in Tris buffer pH7.6. 
 
Alkaline Phosphate Substrate  
Dissolve 8mg of Levamisole (also called (−)-Tetramisole hydrochloride; Sigma Aldrich) in 
10ml Tris buffer (pH 9.2) to block endogenous phosphate activity. In a fume hood dissolve 
4mg of napthol AS-MX phosphate (Sigma Aldrich) in 380μl dimethyl-formamide in a glass 
bottle. Add this to the middle of the levamisole solution, ensuring it does not touch the 
plastic of the tube. Add 10mg of Fast Blue BB salt. Vortex and filter the solution and add a 
single drop to each section until the desired level of positivity is obtained. 
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